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the metabolic activities and interactions of the IM and the 
functional redundancy that may exist are lacking. Thus, the 
current review aims to assess recent literature relating to the 
role played by the IM in the absorption and metabolism of 
key nutrients and non-nutrients.
Methods A systematic review (PROSPERO registration: 
CRD42015019087) was carried out focussing on energy and 
the following candidate dietary substrates: protein, carbo-
hydrate, fat, fibre, resistant starch (RS), and polyphenols to 
further understand the effect of the IM on the dietary sub-
strates and the resulting by-products and host impacts. Par-
ticular attention was paid to the characterisation of the IM 
which are predominantly implicated in each case, changes in 
metabolites, and indirect markers and any potential impacts 
on the host.
Results Studies show that the IM plays a key role in the 
metabolism of the substrates studied. However, with the 
exception of studies focusing on fibre and polyphenols, 
there have been relatively few recent human studies spe-
cifically evaluating microbial metabolism. In addition, com-
parison of the effects of the IM across studies was difficult 
due to lack of specific analysis/description of the bacteria 
involved. Considerable animal-derived data exist, but expe-
rience suggests that care must be taken when extrapolating 
these results to humans. Nevertheless, it appears that the IM 
plays a role in energy homeostasis and that protein microbial 
breakdown and fermentation produced ammonia, amines, 
phenols and branch chain fatty acids, and a greater diversity 
in the microbes present. Few recent studies appear to have 
evaluated the effect of the IM composition and metabolism 
per se in relation with digestible dietary carbohydrate or fat 
in humans. Intakes of RS and prebiotics altered levels of 
specific taxa that selectively metabolised specific prebiotic/
carbohydrate-type substances and levels of bifidobacteria 
and lactobacilli were observed to increase. In controlled 
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human studies, consistent data exist that show a correla-
tion between the intake of fibre and an increase in bifido-
bacteria and short-chain fatty acids, in particular butyrate, 
which leads to lower intestinal pH. Dietary polyphenols rely 
on modification either by host digestive enzymes or those 
derived from the IM for absorption to occur. In the poly-
phenol-related studies, a large amount of inter-individual 
variation was observed in the microbial metabolism and 
absorption of certain polyphenols.
Conclusions The systematic review demonstrates that the 
IM plays a major role in the breakdown and transforma-
tion of the dietary substrates examined. However, recent 
human data are limited with the exception of data from stud-
ies examining fibres and polyphenols. Results observed in 
relation with dietary substrates were not always consistent 
or coherent across studies and methodological limitations 
and differences in IM analyses made comparisons difficult. 
Moreover, non-digestible components likely to reach the 
colon are often not well defined or characterised in studies 
making comparisons between studies difficult if not impossi-
ble. Going forward, further rigorously controlled randomised 
human trials with well-defined dietary substrates and utiliz-
ing omic-based technologies to characterise and measure 
the IM and their functional activities will advance the field. 
Current evidence suggests that more detailed knowledge of 
the metabolic activities and interactions of the IM hold con-
siderable promise in relation with host health.
Keywords Intestinal microbiota · Metabolism · 
Metabolites · Dietary substrates
Introduction
It is well-recognised that humans are colonised by trillions 
of microbes, with an estimated microbial metagenome of at 
least 100-fold that of human cells and that these microbes 
possess a far greater repertoire of metabolic and enzymatic 
capabilities than their human hosts [1–3]. The IM contrib-
ute significantly to human health and may play a role in 
the development and/or prevention of certain non-commu-
nicable diseases. Thus, in relation with nutrition research, 
there is considerable interest in the functional interactions 
between the IM, ingested dietary substrates, and host metab-
olism [4–7]. While there is considerable IM diversity, a few 
phyla predominate: Bacteroidetes, Firmicutes, Actinobac-
teria, Proteobacteria, Verrucomicrobia, Fusobacteria, and a 
limited number of Archaea, mainly methanogens (Fig. 1). 
In addition, despite the consistency of these major phyla, 
their relative proportions and the species present can vary 
dramatically between individuals.
These commensal microbes play a major role in the 
breakdown, absorption, and metabolism of key dietary con-
stituents, contributing, for example, to the breakdown of 
indigestible dietary substrates, vitamin biosynthesis, trans-
formation of compounds to bioactives, and the production of 
various gases as by-products of fermentation. Core functions 
of the IM include pathways associated with carbohydrate 
and amino acid fermentation. However, not all pathways are 
represented in the core and variable functions are sometimes 
restricted to specific species or strains, including, for exam-
ple, vitamin and drug synthesis, metabolism, and nutrient 
Firmicutes
–Clostridium 
–Roseburia
–Faecalibacterium
–F Prausnitzili 
–Blau
a
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–Lactobacillus 
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Proteobacteria
–Escherichia 
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Verrucomicrobia
–Akkermansia
Archaea 
–Methanobrevibacter
-M Smithii
Fig. 1  Main phyla and genera with selected examples of human gut microbiota
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transport. A key challenge is to understand which members 
of the microbial community have similar functionalities and 
can substitute for one another. The IM metabolism extends 
the host’s metabolic capacity through, for example, substrate 
hydrolysis, reduction, and methylation. A more thorough 
understanding of the role the IM plays in the metabolism of 
dietary substrates and of the pertinent and dominant mem-
bers of the IM and community profiles hold considerable 
promise to facilitate the development of novel dietary strate-
gies. This systematic review considers the complex interplay 
and metabolic effects of the IM on energy homeostasis and 
a selection of candidate dietary substrates: protein, digest-
ible carbohydrates, fat, fibres, RS, and polyphenols. Dur-
ing the review, particular attention was paid to the resulting 
metabolites and the characterisation of the IM which was 
predominantly implicated in each case.
Methods
A systematic search of the literature in PubMed was under-
taken to identify relevant human and animal studies. Pub-
lications in English, between March 2005 and 2015, were 
retrieved using a combination of MESH terms and key-
words (metabolism or breakdown, degradation, fermenta-
tion, digestion, transformation, bioavailability, absorption: 
microbiota or bacteria, flora, and microbiome) to identify 
original research examining the effect of the IM on the 
metabolism of energy, protein, fat, digestible carbohydrates, 
fibres, RS, and polyphenols (isoflavones, phenolic acids, and 
flavonoids). Details of the search can be accessed via http://
www.crd.york.ac.uk/PROSPEROFILES/19087_STRAT-
EGY_20161106.pdf. No exclusion criteria were applied in 
relation with health status of the study populations. How-
ever, general reviews, studies involving children less than 
15 years, studies using certain models (ruminants, birds, 
and ileostomised subjects), and in vitro data were excluded 
from the assessment. Studies dealing with the impact of the 
dietary substrates on the IM composition alone or effects 
on the host as well as studies not including an analysis of 
the IM were also excluded in the course of the screening 
of the abstracts and papers unless metabolites were meas-
ured. The process applied for literature selection is sum-
marised in Fig. 2. Each abstract and subsequently each 
selected paper was screened independently for eligibility by 
two individuals. In the case of disagreement, consensus was 
reached by discussion. The review followed the approach of 
the Preferred Reporting for Systematic Reviews and Meta-
Analysis Guidelines [8]. Details of the systematic review 
were registered in the PROSPERO International Prospec-
tive Register of Systematic Reviews (registration number 
CRD42015019087) (http://www.crd.york.ac.uk/PROS-
PERO) and selected details of the studies included in the 
review are provided. During the systematic evaluation, study 
data were reviewed, where possible, in relation to substrate 
disappearance, appearance of metabolites, changes in the 
IM composition, and any reported metabolic consequences 
in human and animal studies, respectively.
Results
Impact of the intestinal microbiota on energy 
homeostasis
The IM has coevolved with the human host to perform a 
number of functions that would otherwise not be accom-
plished without the IM. Data from studies involving humans 
and germ-free (GF), lean, and obese animals suggest that 
the IM plays an important role in the assimilation, storage, 
and expenditure of energy obtained from dietary substrates. 
For example, while interacting symbiotically with each 
other and with the intestinal environment, members of the 
IM break down non-digestible polysaccharides, producing 
monosaccharides and short-chain fatty acids (SCFA), and 
allow the host to salvage energy from otherwise indigest-
ible dietary substrates. The IM also affects energy balance 
through metabolites it produces by regulating gene expres-
sion. Overall, 22 publications were identified in relation with 
the IM and energy homeostasis, and of these, nine human 
[9–17] and 13 animal [18–30] studies were reviewed. In the 
human studies, the number of subjects varied from 12 to 80 
and the study duration varied from 1 day to 6 months. Of 
the human studies, five involved normal weight subjects, 
three involved obese subjects, and one compared lean and 
obese subjects.
Data from human studies relating to energy 
homeostasis
Studies addressing the role of the IM in the host energy 
homeostasis have assessed energy either as the amount 
of energy in faeces measured by bomb calorimetry 
(energy that has not been used either by the host or by 
the microbes), a change in body mass index (BMI, kg/
m2), and/or changes in weight. Change in the amount of 
SCFA in faeces was also recorded, though it should be 
noted that the role of faecal SCFA in energy homeosta-
sis has yet to be fully clarified. The effect on the IM in 
healthy humans on a regular diet was compared with the 
same diet either devoid or supplemented with a formula 
with 14 g/l of pea fibre and fructo-oligosaccharide (FOS) 
[10]. The fibre-free diet was associated with a decline in 
all microbial species and total SCFA. Butyrate was the 
only SCFA reduced during the fibre-supplemented diet and 
this reduction was correlated with a proportional decrease 
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Records identified through 
database searching
(n = 730)
Records screened
(n = 730)
Records excluded
(n = 522)
Full-text articles assessed for 
eligibility (per substrate)
Energy (n = 50)
Carbohydrates (n = 16)
Protein (n = 17)
Fat (n = 9)
Fibres (n = 43) 
Resistant starch (n = 7)
Polyphenols (n = 66)
Full-text articles excluded, with reasons
Energy (n = 28)
20 “use of inadequate models” + 2 “effect of diet on 
microbiota/host without information on metabolite 
production” + 6 “review articles”
Carbohydrates (n = 13)
4 “use of inadequate models” + 2 “effect of diet on 
microbiota/host without information on metabolite 
production” + 7 “not dealing with the dietary compound”
Protein (n = 11)
9 “use of inadequate models” + 1 “effect of diet on 
microbiota/host without information on metabolite 
production” + 1 “not dealing with the dietary compound”
Fat (n = 5) 
4 “use of inadequate models” + 1 “effect of diet on 
microbiota/host without information on metabolite 
production”
Fibres (n = 20)
12 “use of inadequate models” + 1 “studies in young 
children” + 2 “effect of diet on microbiota/host without 
information on metabolite production” + 1 “not dealing 
with the dietary compound” + 4 “a computer based 
simulation/calculation”
Resistant starch (n = 0)
Polyphenols (n = 43)
41 “use of inadequate models” + 2 “review articles”
Studies included in qualitative 
synthesis (per component)
Energy (n = 22)
Carbohydrates (n = 3)
Protein (n = 6)
Fat (n = 4)
Fibres (n = 23)
Resistant starch (n = 7)
Polyphenols (n = 23)
Fig. 2  Search phases of the systematic review
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of Faecalibacterium prausnitzii [10]. This was the first 
study to show a strong positive correlation between the 
proportion of F. prausnitzii and that of butyrate in indi-
viduals on a normal diet and that the reduction in F. praus-
nitzii on switching to a fibre-free or fibre-supplemented 
diet correlated with the reduction in faecal butyrate. It 
has also been shown that a change in composition of the 
IM was associated with a change in energy lost in faeces 
in lean individuals; a 20% increase in Firmicutes and a 
corresponding decrease in Bacteroidetes increased energy 
harvest by 150 kcal [12]. IM metabolism was also explored 
following sleeve gastrectomy and weight loss. Butyrate 
production was reduced and correlated with a decrease in 
butyrate-producing microbes Coprococcus spp., Eubacte-
rium rectale, Ruminococcus obeum, and Lachnospiraceae. 
In addition, excretion of non-esterified fatty and bile acids 
was increased and correlated with an increase in the ratio 
of Bacteroidetes/Firmicutes; there was also an increase 
in B. vulgatus, and Bacteroides spp., F. prausnitzii, and a 
decrease of Firmicutes: Clostridium, Eubacterium, Dorea, 
and Coprococcus spp. The authors highlighted that the 
energy-reabsorbing potential of the IM decreased follow-
ing gastrectomy as indicated by the Bacteroidetes/Firmi-
cutes ratio [13]. Others have reported a decreased con-
centration of Clostridium histolyticum, C. lituseburense, 
E. rectale/C. coccoides, and increased concentration of 
Bacteroides/Prevotella was associated with a significant 
increase in weight loss [14]. Rahat-Rozenbloom reported 
an increased production of colonic SCFA correlated with 
a higher concentration of Firmicutes, as well as a higher 
ratio of Firmicutes/Bacteroides in obese compared to 
lean individuals and suggested that the effect of diet and 
colonic flora on faecal SCFA in lean and obese warrants 
further attention [15]. Ross and colleagues compared 
urinary and faecal metabolites after either a refined or 
a whole grain (WG) diet [16]. The WG diet induced an 
increase in faecal acetate and butyrate, and a decrease in 
isovalerate and succinate which correlated with a decrease 
in C. perfringens, C. difficile and an increase in C. leptum. 
Others have explored the relationship between the IM and 
BMI in a cohort of monozygotic twins [17]. The IM of 
the cohort of monozygotic twins divided into a ‘low BMI’ 
and a ‘high BMI’ sibling group showed that at the phylum 
level, Bacteroides/Firmicutes ratio was similar, and at the 
group level, Clostridium cluster IV diversity decreased 
with increasing BMI. At the genus level, E. ventrosium, 
R. intestinalis, and E. rectale were more abundant in the 
higher BMI group, while more plant degrading microbes, 
O. guilliermondi, C. cellulosi, R. bromii, and S. termitidis 
were more abundant in the ‘low BMI’ group which also 
had lower faecal SCFA concentrations. The authors sug-
gested that the differences in IM and fermentation patterns 
could have affected energy homeostasis.
Data from animal studies relating to energy 
homeostasis
When mice with different IM (a conventional control, a sim-
plified human model with and without C. ramosum and C. 
ramosum alone) were used in a comparison test [19], mice 
harboring C. ramosum, a member of the Erysipelotrichi class 
within the Firmicutes phylum, alone or with seven other spe-
cies, gained more weight and body fat and displayed a higher 
feed efficiency than the group without C. ramosum. These 
effects were associated with an increased gene expression of 
a glucose transporter and an epithelial fatty acid translocase, 
leading to enhanced bioavailability. Romo-Vaquero and col-
leagues [23] modulated the IM of lean and obese Zucker rats 
with a Rosemary extract and reported a higher SCFA content 
in faeces from obese compared to lean rats. In lean rats, a 
specific increase in the level of Bifidobacterium genus and 
reduction of C. leptum group correlated with a significant 
reduction of SCFA. However, the increase in B. coccoides, 
Bacteroides/Prevotella, and decrease in Lactobacillus/
Leuconostoc/Pediococcus, did not change the percentage 
of proteins, fat, fibre, or carbohydrates excreted in faeces. 
A correlation between a fibre/RS induced IM change, an 
increase of bifidobacteria, a decrease in Bacteroides/Prevo-
tella, Porphyromonas, and Enterococcus, and an increase in 
colonic SCFA and branch chain fatty acids (BCFA), was also 
reported in rats fed diets containing red meat [24]. Others 
have used dietary RS to increase the caecal concentration 
of SCFA producing microbes, Bacteroides spp., Bifidobac-
terium spp., Lactobacillus spp., and Clostridium clusters IV 
and XIV [32] and reported an increase in SCFA concentra-
tion. Based on tests in an n-3 polyunsaturated fatty acids 
depleted mouse model [25], an increase in body weight was 
reported after a FOS induced increase of Bifidobacterium 
and Bacteroides without an increase in food intake. At the 
same time, they reported an increase in confounding mecha-
nisms, such as an increase in glucagon-like peptide (GLP-
1). This increase in body weight following FOS intake is 
in direct contrast to many studies showing a reduction in 
weight following prebiotic intake. The authors suggested 
that FOS promoted body weight gain in the n-3 depleted 
mice by increasing energy efficiency through increasing 
lactobacilli and counteracting the catabolic status induced 
by n-3 polyunsaturated fatty acid depletion. Others have 
demonstrated [22] that colonizing GF mice with B. thetaio-
taomicron and M. smithii nearly doubles their daily weight 
gain, and increases fat pad weight by 50%. Firmicutes were 
shown to increase bioavailability of fatty acids by increasing 
the number of lipid droplets in the intestinal epithelium in 
a Zebra fish model and the authors concluded that different 
members of the IM may affect fatty acid absorption via dis-
tinct mechanisms [31].
 Eur J Nutr
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Until now, there have been relatively few human studies 
of long duration that explored the role of the IM in rela-
tion with energy homeostasis and results in animals need 
to be interpreted with caution. The complexity of bacterial 
classification and the varied analytical methods used also 
add challenges in interpreting results in relation with energy 
homeostasis: for example, within an order like Clostridi-
ales, different species may have completely different effects; 
therefore, specificity is required to fully interpret effects. 
Many studies also report various effects of dietary intakes 
without fully defining composition or chemical structure of 
specific substrates that impact on SCFA production, such 
as undigested carbohydrates or fibre. This makes compar-
ing relative SCFA production very difficult when we cannot 
control precisely for quantities of substrate present. In addi-
tion, it is also difficult to relate faecal SCFA, with either 
SCFA production or energy availability to the host, from 
IM activity without concomitant or dynamic measures of 
plasma SCFA. Unfortunately, such dynamic blood SCFA 
flux experiments following food ingestion are few though 
warranted to increase understanding particularly in relation 
with energy homeostasis.
Impact of the intestinal microbiota on the metabolism 
of macro‑nutrients
A significant proportion of dietary carbohydrates, proteins, 
and all fats are absorbed before entering the large intestine. 
However, if it were not for the IM, the indigestible carbo-
hydrates and proteins reaching the colon would be elimi-
nated in the stool without further absorption. Few recent 
human studies have investigated the impact of the IM on the 
bioavailability and/or the bacterial metabolism of macro-
nutrients (digestible carbohydrates, proteins, and fat) as 
they are largely absorbed in the early part of the gut and 
modifications observed seem to reflect the balance between 
these three digestible macro-nutrients. For digestible car-
bohydrates, no study in humans was identified that met our 
inclusion criteria, therefore, only data on animal models 
are presented [33–35]. For proteins, we identified six pub-
lications [34–39]. Of these, one was conducted in humans 
involving 11 subjects [38] and five involved animal models 
[34–37, 39]. For fats, one study conducted in humans with 
15 subjects [40] and three in animals were identified [21, 
41, 42].
Data from animal studies on digestible carbohydrates
In a study on Beagle dogs, metabolites produced follow-
ing 3 weeks of a control diet (providing crude proteins and 
RS) or a high-starch diet or a high-protein diet were com-
pared [34]. Higher total SCFA was observed with the high-
starch and control diets compared to the high-protein diet. 
The high-starch diet led to lower concentrations of faecal 
valerate, BCFA, and ammonia concentrations compared to 
the high-protein diet. Another study investigated the effect 
of four different diets in pigs with a T-cannula at the dis-
tal ileum: in particular, a control diet based on corn and 
soybean meal or three diets containing 75% of the control 
diet and 25% being replaced by ligno-cellulose, apple pec-
tin, or corn starch [35]. The starch diet induced a two-fold 
higher total SCFA change compared to cellulose and apple 
pectin-based diet in the ileum and two-fold less total SCFA 
change compared to the apple pectin diet only in the fae-
ces. There was a lower ileal pH following the apple pectin 
diet, whereas the cellulose-containing diet increased faecal 
pH. No significant difference was observed in the ileal and 
faecal SCFA concentrations between the starch and control 
diets. The differences observed between the starch diet and 
both the cellulose and apple pectin diets can be explained 
by the fact that starch is considered an easily fermentable 
source of carbohydrates in the small intestine which results 
in higher ileal concentrations of SCFA compared to pectin 
and cellulose and that this effect disappears in the distal 
parts of the intestine due to the higher digestibility of starch 
resulting in it either not reaching the colon or doing so only 
in small amounts. Ileal and faecal phosphorus recovery was 
also reduced after the cellulose- and starch-based diets. The 
starch diet increased the net phosphorus absorption from the 
large intestine compared to the cellulose and pectin-based 
diets. On the other hand, cellulose and pectin-based diets 
tended to cause a net phosphorus secretion into the large 
intestine. These differences in phosphorus absorption may 
reflect different bacterial requirements for the fermentation 
of the different carbohydrates tested. Indeed, it is known 
that degradation of cellulose and hemicellulose requires 
more phosphorus than the degradation of starch [43]. The 
effect of diets with differing ratios of digestible and RS was 
investigated in rats [33]. They were provided with diets con-
taining 25% of casein and 0, 10, 20, 30, or 40% of high-
amylose maize starch (HAMS, which is high in RS in place 
of corn starch) for 4 weeks [33]. The mucus layer thickness 
increased with increasing amount of HAMS in the diet and 
caecal total SCFA, acetate and propionate were significantly 
increased when HAMS was greater than 20% of the diet, 
whereas butyrate was increased with 10% of HAMS in the 
diet and further increased with 40% compared to the diet 
with only digestible corn starch. On the other hand, faecal 
acetate and total SCFA increased with 10, 20, and 40% of 
HAMS in the diet, but no difference was observed for pro-
pionate and butyrate. A significant correlation was found 
between major SCFA and caecal pH. Another interesting 
indirect effect observed [33] is that colonic DNA damage 
decreased with the increasing HAMS content of the diet. 
This effect was positively correlated with the major SCFA 
and to the colonic pH. The strongest inverse correlation was 
Eur J Nutr 
1 3
observed between caecal butyrate and the level of DNA 
damage. In addition, a strong negative correlation was also 
observed between the mucus layer thickness and colonic 
DNA damage.
Due to the ability of the IM to rapidly alter its physiol-
ogy, it is able to adapt to different dietary carbohydrates 
from meal to meal. Few studies considered in the systematic 
review have evaluated the effect of digestible carbohydrates 
on IM metabolism and none have provided information on 
microbial composition. This could be due to the fact that 
most of the digestible carbohydrates are metabolized and 
digested in the upper gut and do not reach the colon. How-
ever, it is worth noting that a large intervention study, found 
during a subsequent hand search, has reported that high 
carbohydrate diets increase saccharolytic bacteria includ-
ing bacteroides and bifidobacteria, which have been inde-
pendently associated with improved body energy regulation 
[44].
Data from a human study on dietary proteins
The change in IM composition and activity in healthy vol-
unteers were investigated when the usual diet was shifted 
to an animal- or a vegetable-based diet [38]. The animal-
based diet had increased fat and protein and decreased fibre 
content, whereas the vegetable-based diet had increased 
fibre and decreased fat and protein contents. The authors 
found differences in the metabolite production, where the 
vegetable-based diet led to an increase in faecal acetate and 
butyrate content. On the other hand, the animal-based diet 
led to an increased production of isovalerate and isobu-
tyrate. The animal-based diet significantly increased the 
levels of faecal deoxycholic acid (DCA) which is a second-
ary metabolite of bile acids produced by microbial metabo-
lism. Elevated DCA concentrations may have contributed to 
microbial disturbances in the animal-based diet, as this bile 
acid can inhibit the growth of members of the Bacteroidetes 
and Firmicutes phyla. Changes in IM composition due to the 
shift from the animal- to the vegetable-based diet were also 
investigated through 16S rRNA Illumina sequencing [38]. 
There was a significant increase in diet-associated-diversity 
that was unique to the animal-based diet. This effect was 
reversed 2 days after this diet ended. The animal-based 
diet increased abundance of Alistipes, Bilophila and Bacte-
roides, which is consistent with the higher bile acid secretion 
induced by the higher fat intake. It also decreased the levels 
of Firmicutes such as Roseburia, E. rectale, and R. bromii 
that metabolize dietary plant polysaccharides. The animal-
based diet was also associated with increased expression 
of bacterial genes for vitamin biosynthesis, degradation of 
polycyclic aromatic hydrocarbons, and increased expression 
of β-lactamase genes. There was a significant positive cor-
relation between subjects’ fibre intake over the past year 
and baseline intestinal Prevotella levels. Significant posi-
tive relationships between clusters composed of putrefactive 
microbes (i.e., Alistipes putredinis and Bacteroides spp.) and 
isovalerate and isobutyrate, which are end-products of amino 
acid fermentation, were also found [38].
Data from animal studies on dietary proteins
In relation to the absorption of proteins in the gut [45], a 
meta-analysis of the results of studies performed in pigs 
observed that the apparent ileal and total tract digestibil-
ity of crude proteins decreased by 15–20 and 10%, respec-
tively, when β-glucans increased up to 6% of the diet. The 
authors also observed an effect with xylose which was lower 
than β-glucans. Others have studied protein recycling and 
the contribution of microbial lysine to amino acid metab-
olism in growing rabbits [37]. Animals were divided into 
three groups: one group received a control diet, one group 
received a diet supplemented with the isotope 15NH4Cl, and 
one group initially received the control diet, and then, the 
diet supplemented with the isotope while wearing a neck 
collar to avoid caecotrophy for the last 10 days of the test 
period which lasted 30 days in total. They observed differ-
ences in the pattern of amino acids between caecal bacteria 
and caecotrophic material, with tyrosine and methionine 
being higher and threonine and proline lower in the cae-
cal bacteria compared to the caecotrophic material. In the 
neck collar group, lysine of caecotrophes showed lower 15N 
enrichment compared with bacteria in the isotope group, due 
to dilution with the endogenous lysine of the mucous enve-
lope. As for lysine, enrichment in most amino acids, except 
proline, was higher in bacteria than in caecotrophes. The 
contribution of microbial lysine to total absorption repre-
sented about one-quarter of the total absorbed lysine, mostly 
due to the caecotrophy process (97%) and only 3% to direct 
intestinal absorption. Others have examined the effect of a 
high-protein diet with starch in Beagle dogs [34] and found 
a higher faecal pH in the high-protein group compared to the 
control group. Total SCFA, particularly acetate and propion-
ate, were significantly lower in the high-protein diet group 
compared to the control and the high-starch diet groups. 
Valerate and BCFA were higher following the high-protein 
diet compared to the control and the high-starch diets. The 
effect of the source of dietary proteins in rats on metabolic 
effects has been evaluated [36].
The effect of the source of dietary proteins has also been 
evaluated in rats fed diets providing 20% protein from soy, 
casein, or fish for 16 weeks. While no differences were 
observed in caecal pH, some differences were observed in 
caecal SCFA. The fish protein diet led to an increase in total 
SCFA and lactic acid, which was two times higher than in 
animals fed the casein or the soy protein diets. Butyrate con-
centration was greater after the soy diet compared to the 
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two other groups. No differences were observed for acetate 
and propionate. Caecal indole concentration was two times 
higher with the fish and soy diets compared to the casein 
diet.  H2S and phenol were also higher with soy and fish diets 
versus the casein diet. Ammonia tended to be higher with 
the fish diet compared to the other diets.
The effect of two diets, one with medium protein and 
carbohydrates (MPMC) and one with high protein and low 
carbohydrates (HPLC), was investigated on the IM structure 
in kittens [39]. Deep shot-gun sequencing revealed higher 
species richness and diversity was induced by the HPLC diet 
compared to the MPMC diet. Moreover, there was higher 
proportion of rare genera in the faecal microbiota of kittens 
fed the HPLC compared to the MPMC diet. Interestingly, the 
IM compositions were more similar within the HPLC group 
compared to MPMC group. The microbiomes of kittens fed 
the MPMC diet included bacteria with genes with a greater 
abundance in pathways associated with the biosynthesis of 
amino acids, vitamins, fatty acids, and peptidoglycans; the 
glycolytic, tricarboxylic acid cycle, and pentose phosphate 
pathways; and oxidative phosphorylation and the metabolism 
of purines, pyrimidines, and sugars. In contrast, the micro-
biomes of kittens fed the HPLC diet had greater abundance 
of genes associated with flagellar assembly, chemotaxis, 
sporulation, and two-component systems. Fusobacterium, 
Clostridium, Eubacterium, Ruminococcus, Bacteroides, 
Desulfovibrio, and Proteobacteria were significantly more 
prevalent in HPLC group compared to the MPMC group. 
Fusobacterium, Clostridium, and Desulfovibrio are some-
times associated with intestinal disease, but the kittens in 
this study were healthy. Therefore, their presence was more 
likely due to their ability to ferment protein-based substrates. 
On the other hand, there were more Firmicutes and Actino-
bacteria in MPMC group compared to HPLC group. Meg-
asphaera were in much greater proportions in kittens fed 
MPMC compared to HPLC. Megasphera have the ability 
to ferment lactate into several SCFA, including butyrate. 
In the same way, Bifidobacterium and Acidaminococcus 
were predominant genera and in much greater abundance 
in the MPMC- versus HPLC-fed kittens as well as Sele-
nomonas and Prevotella. Selenomonas have the ability to 
use a wide variety of nitrogen- and carbon-based substrates. 
These results confirm data obtained in humans, where it was 
observed that Bacteroides tend to be more abundant in those 
eating diets high in protein and animal fats and Prevotella in 
those eating high carbohydrate diets [46]. The more diverse 
and less variable composition of IM observed for the HPLC 
diet reflects a specialized microbiota, while the less diverse 
and more variable structure on the MPMC diet reflects a 
more generalised microbiota.
The type of protein also has an impact on the composi-
tion of the IM [36]. 16S rRNA gene-denaturing gradient gel 
electrophoresis (DGGE) and pyrosequencing were used to 
show that there was greater bacterial diversity with a soy 
diet and less diversity with a casein diet. Lactobacilli were 
detected in all groups but not of the same strain. The most 
typical bacteria with the casein diet were B. pseudolongum, 
while it was Bacteroidetes in the soy diet group. Moreover, 
41% of the DGGE bands were identified as C. bifermentans, 
C. orbiscindens, C. xylanolyticum, or other Clostridiales. 
Lachnospiraceae and P. excrementihominis were detected 
only with fish diet. There was no difference at the phylum 
level between the three groups with Firmicutes predomi-
nating and the rest being Bacteroidetes. There was more 
Ruminococcaceae with the soy diet than with the two other 
groups. With this detection method, there were more lacto-
bacilli with the fish diet followed by the casein diet and the 
soy diet displaying the lowest amount of lactobacilli. Bacte-
roidaceae were only detected with fish diet, whereas with the 
pyrosequencing method, Lachnospiraceae were dominant in 
casein and soy diets. L. incertae Sedis and Enterococcus 
were detected only following the soy diet.
In summary, while only a small number of recent studies 
complied with the review criteria, high-protein diets gener-
ally led to a decrease in the total SCFA production and in 
particular of acetate and propionate. On the contrary, valer-
ate and BCFA concentrations, especially isovalerate and 
isobutyrate, were increased. Some studies have also shown 
increased concentrations of secondary metabolites of bile 
acids, particularly of DCA and of ammonia. Considering 
the effect of protein on IM composition, it was interesting 
to see a greater diversity in the microbes present in the gut 
and higher proportion of rarer genera. In humans, there was 
an increase in Bilophila, Alistipes, Bacteroides, and several 
bacteria from the Firmicutes phylum (Roseburia, E. rectale, 
and R. bromii). The increases in Alistipes and Bacteroides 
were correlated with the higher concentrations of BCFA. In 
animal models, increased concentrations of Fusobacterium, 
Clostridium, Eubacterium, Ruminococcus, Bacteroides, 
Desulfovibrio, and Proteobacteria were observed, whereas 
Firmicutes, Actinobacteria, Megasphaera, Bifidobacterium, 
Acidaminococcus, Selenomonas, and Prevotella were more 
prevalent in the medium protein diet compared to the high-
protein diet. These results are not totally consistent with the 
observations in humans possibly due to the differences in the 
composition of the IM in these different models. Moreover, 
different methods are used to characterize the IM composi-
tion, leading to the observation of different results, high-
lighting the difficulty in comparing and interpreting results 
across studies utilizing different methodologies.
Data from animal and human studies on dietary lipid
Results from a study in which rats fed for 20 weeks with a 
control diet or a high-fat diet with or without Agaricus blazei 
Murill extracts showed that the high-fat diet led to a slight 
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but significant decrease in total bacterial count. There was 
also a profound decrease (by about 100-fold) in Lactobacil-
lus spp. No effect was observed on Bifidobacterium spp. 
[21]. Moreover, differences were in lipid metabolism were 
observed when two strains of mice (129S6 and BALBc) 
were fed with diets providing either 5 or 40% of fat (con-
sisting of 40% lard and 8% corn oil) for a 4 month period 
[41]. In striking contrast to the BALBc mice, the 129S6 mice 
on the high-fat diet mainly excreted methylamines, namely, 
dimethylamine, trimethylamine (TMA), and trimethylamine 
oxide (TMAO), which are choline derivatives produced by 
the IM. No evaluation of the IM was performed. It has been 
shown that these metabolites are solely derived from com-
mensal bacteria, and not from mammalian, metabolism. 
Indeed, GF mice do not excrete TMA and thus indicate the 
fundamental role of the IM in TMA production from its 
precursor choline. Foods rich in phosphatidylcholine, which 
predominantly include eggs, milk, liver, red meat, poultry, 
shell fish, and fish, are believed to be the major dietary 
sources for choline, and hence TMAO production. Two 
other studies [40, 42] have investigated the effect of IM and 
dietary fat on the production of methylamines. Free-living 
lacto-ovo-vegetarian women were fed six n-3-enriched eggs 
per week or six non-enriched eggs per week or an egg-free 
control period for 8 weeks. The n-3 enriched egg treatment 
led to higher plasma free choline and betaine versus the 
egg-free period. No difference was observed between the 
enriched and non-enriched egg-treatment groups, even with 
regard to plasma TMAO concentrations [40]. In a challenge 
test [42], the conventional and GF mice were fed egg-yolk 
with previous or no administration of antibiotics. TMAO 
was detected in the control mouse group only; the GF mice 
or mice having received antibiotic treatment had no or very 
low concentrations of TMAO.
Few data are available to allow conclusions to be drawn 
regarding the impact of the IM on dietary fat. Most of the 
studies retrieved were dealing with the production of methy-
lamines. Indeed, high-fat diets led to increased production of 
TMA and TMAO, which are risk factors for cardiovascular 
disease and TMAO is considered both a biomarker and a 
renal toxin [47]. Concerning the IM composition, high-fat 
diets appear to lead to reduced diversity with a report of a 
decrease in Lactobacillus spp. [21].
Impact of the intestinal microbiota on the metabolism 
of fibre
Recent definitions of fibre have included polysaccharides, 
such as inulin, and oligosaccharides, such as FOS and 
galacto-oligosaccharides (GOS), as sources of dietary fibre 
based on their physiological effects. Due to the wide variety 
of dietary fibres with different structures and chemical com-
positions, distinct differences in fermentation patterns are 
observed. Fibre and prebiotic oligosaccharides are known 
to resist digestion in the small intestine and reach the colon, 
where they are fermented by the IM. A total of 23 publica-
tions were identified. Of these, seven consisted of human 
trials [10, 16, 48–52], and 16 studies were conducted using 
animal models [26, 53–67]. The number of subjects in the 
human trials varied from 10 to 58 and the study duration 
varied from 2 to 12 weeks.
Data from human studies on fibre
A randomized controlled trial [51], including 30 obese 
women consuming a mixture of inulin and oligofructose 
(16 g/day) or placebo, was conducted for 12 weeks. IM 
changes after dietary intervention were monitored using 
phylogenetic microarray and qPCR analysis of 16S rDNA. 
Significant increases were found for the Firmicutes groups 
Clostridium cluster IV and XIVa. At genus and species 
levels, significant increases were found for bifidobacteria, 
lactobacilli, and F. prausnitzii and decreases in Propioni-
bacterium, B. intestinalis, and B. vulgatus were observed. 
In addition, the prebiotic treatment significantly decreased 
post-oral glucose tolerance test glycaemia. Interestingly, sev-
eral correlations were found between changes in the faecal 
microbiota and host metabolism. Levels of faecal Bifido-
bacterium spp. and F. prausnitzii correlated negatively with 
serum lipopolysaccharide levels. In contrast, Propionibac-
terium and B. vulgatus were both decreased by the inulin-
type fructans, and positively correlated with plasma levels of 
phosphatidylcholine and lactate, which were associated with 
lower adiposity. Moreover, in this human study, changes in 
Propionibacterium and B. vulgatus positively correlated 
with changes in fat mass and glucose homeostasis. In addi-
tion, significantly increased levels of Collinsella were found 
with inulin-type fructan consumption, and these correlated 
with higher urinary levels of hippurate, a gut-derived metab-
olite which is decreased in diabetes and obesity.
A mixture of pea fibre and FOS supplemented at 14 g/l of 
formula provided to 10 healthy adults for 2 weeks induced 
a significant increase in faecal bifidobacteria in comparison 
with a fibre-free diet as measured by fluorescence in situ 
hybridization (FISH). Both the fibre-supplemented and 
fibre-free diets were shown to decrease the abundance of 
faecal F. prausnitzii and Roseburia spp. compared with 
baseline. The abundance of the Bacteroides group decreased 
significantly during the fibre-fee diet. Faecal SCFA levels 
decreased significantly on the fibre-free diet, while only 
butyrate was reduced following the fibre-supplemented diet. 
As highlighted earlier, a significant positive correlation was 
found between the change in proportion of F. prausnitzii and 
acetate and butyrate following the fibre-supplemented diet 
and between the change in proportion of F. prausnitzii and 
butyrate following the fibre-free diet [10]. Two randomized 
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controlled trials in healthy adults demonstrated that sup-
plementation with wheat bran extract, a fraction rich in 
arabinoxylan oligosaccharides, also increases faecal Bifido-
bacterium spp. content relative to control groups [50, 52]. 
Cloetens et al. [52] investigated 20 healthy adults consuming 
their usual diet supplemented with 13.9 g/day of wheat bran 
extract or maltodextrin. In particular, the abundance of B. 
adolescentis, as measured by quantitative PCR, was found 
to be significantly increased and the levels of lactobacilli 
were decreased compared with control. In the other study 
[50], significantly increased levels of bifidobacteria were 
detected by FISH upon consumption of 10 g/day of wheat 
bran extract by 58 healthy adults. No significant changes 
in total bacteria or other bacterial groups were found in 
the respective studies [50, 52]. In addition, consumption 
of 10 g/day of wheat bran extract significantly decreased 
urinary p-cresol, a marker of proteolytic fermentation, and 
significantly increased faecal total SCFA levels and, in turn, 
decreased stool pH [50]. In two randomised, double-blind, 
placebo-controlled trials [49], the effect of different dosages 
of the soluble fibre Nutriose, a resistant dextrin derived from 
wheat or maize starch, on the faecal microbiota was inves-
tigated. Forty-eight healthy individuals received 10, 15, or 
20 g of Nutriose per day or a product control (glucose) for 
14 days in the first trial. In the second trial, 8 g/day Nutriose 
or the product control was given for 14 days to 40 healthy 
individuals. Nutriose, in general, increased the number of 
Bacteroides and decreased C. perfringens numbers in fae-
ces. In addition, the β-glucosidase activity was enhanced 
and faecal pH was lowered by Nutriose consumption. The 
authors hypothesized that the increased fermentation activity 
led to a lower colonic pH (although no significant change in 
SCFA was shown), which may have inhibited the growth of 
potential pathogens like C. perfringens.
The impact of a WG rich diet and a refined-grain (RG) 
diet has also been examined [16, 48]. Due to the inherently 
high-fibre content of WG cereals compared with their refined 
counterparts, it has been hypothesized that WG cereals may 
play a role in modulating the IM and alter intestinal transit. 
In a randomized, researcher-blinded, cross-over study with 
17 healthy subjects that received a 2-week intervention diet, 
faecal C. leptum and Enterococcus spp. populations were 
shown to increase after the WG diet, along with a trend for 
decreased faecal water pH and increased stool frequency 
compared with the RG diet. The C. leptum population is 
known to contain a number of bacterial species adapted for 
utilizing fibre as a substrate and producing butyrate. The 
observed trend for a decrease in faecal pH with the WG diet 
fits with the increase in butyrate-producing bacteria. On the 
basis of metabolic changes, as measured in plasma, urine, 
and faecal water, the WG diet affected a variety of path-
ways, including protein, lipid, and microbial metabolism. 
Protein-derived IM metabolites were lower during the WG 
diet, suggesting that more carbohydrate was available in the 
distal colon, reducing the use of protein as a substrate. The 
WG diet lowered faecal excretion of isovalerate, a product 
of amino acid metabolism by the IM also found to decrease 
during diets high in fermentable carbohydrates in other 
studies. The observed changes in IM composition were also 
reflected in the urinary metabolic profile, e.g., a lower uri-
nary excretion of 4-hydroxyphenylacetate; a colonic metabo-
lite of tyrosine and phenylalanine breakdown (by C. perfrin-
gens and C. difficile, respectively) was evident. The urinary 
metabolic profiling also revealed differences in response to 
the diets due to gender differences: urinary fumarate differed 
between the WG and RG group in woman, but not in men. 
Interestingly, this gender difference has also been observed 
in other metabolic profiling studies.
Data from animal studies on fibre
Rats provided a diet containing either unprocessed pom-
ace from apple juice pressings (61% fibre), or ethanol- and 
ethanol/acetone-extracted pomace (66% fibre) for 4 weeks 
[64] exhibited an increase in caecal SCFA and a decrease in 
BCFA accompanied by lowered small intestine and colonic 
pH compared to control-fed rats. Jeon and Choi [62] fed rats 
with a normal diet, a diet containing 10% lactic acid bacteria 
and a diet with 2% lactic acid bacteria-fermented germinated 
barley for 6 weeks. Germinated barley contains glutamine-
rich proteins and insoluble dietary fibres and this fibre sup-
plementation resulted in enhanced caecal SCFA production. 
The primary outcome of the study was the improvement of 
intestinal transit and an increase of faecal mass in a lopera-
mide-induced model of constipation.
The faecal metabolic changes in different IM models were 
monitored when a probiotic or a symbiotic (probiotic plus 
prebiotic fibre) was supplemented to the diet [65]. GF mice 
were colonised either by exposure to normal environment 
(conventionalised) or with a simplified human baby micro-
biota (HBM), and the conventional mice served as controls. 
Interestingly, HBM mice displayed different metabolic pat-
terns in the faeces in comparison with the conventional and 
conventionalised mice. The level of acetate, butyrate, and 
propionate was decreased, but also lactate, 5-aminovalerate, 
bile acids, tyrosine, glucose, and U3 (unassigned metabo-
lite, most likely fatty acid related compound) amounts were 
lower, while choline, citrate, creatine, and succinate lev-
els were increased. In addition, between the conventional 
and conventionalised mice, some differences in the con-
tent of fatty acids in faeces were observed. This has also 
been found in other ex-GF mice previously and might be a 
long-term consequence of the GF state. The conventional-
ised mice only differed from conventional mice in a lower 
intestinal lactobacilli count. The IM of the HBM mice har-
boured higher populations of enterobacteria, bacteroides, 
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and staphylococci. C. perfringens was present and lacto-
bacilli were absent in comparison with the conventional 
and conventionalised mice. Furthermore, when HBM mice 
received a probiotic diet with or without GOS (3 g/100 g) 
for a period of 14 days, the supplementation with the GOS 
resulted in higher numbers of bifidobacteria and lactobacilli, 
lower levels of unassigned fatty acids and higher content of 
oligosaccharides, and a higher increase in acetate over time 
[65]. Others have studied the impact of different types of 
GOS on the IM [60]. For 14 days, rats were fed a standard 
diet alone or a standard diet with either GOS derived from 
lactulose (GOS-Lu) or a GOS derived from lactose (GOS-
La). Faecal samples revealed an increase in bifidobacteria 
with both GOS types. Compared to each other, GOS-Lu had 
a significantly stronger bifidogenic effect, whereas GOS-La 
increased lactobacilli more significantly. Compared to con-
trols, both types of GOS raised counts of E. rectale and C. 
coccoides in the faecal microbiota. In relation with GOS 
metabolism, the caecum and faecal samples clearly showed 
that both GOS were readily fermented in the large intestine. 
In addition, a 3-week dietary enrichment study with GOS 
resulted in a reduced energy intake of GOS-fed rats [26] and 
increased colonic lactic acid levels, a primary GOS metabo-
lite from bifidobacteria and lactobacilli species that becomes 
abundant on diets containing GOS [26]. This reduction in 
energy intake in response to GOS diets is in line with results 
reported for other fermentable fibres, e.g., FOS, inulin, and 
RS. Epididymal fat weight, a marker of abdominal fat mass, 
was distinctly lower in GOS-fed rats. This could be a gen-
eral consequence of reduced energy intake and/or a specific, 
direct effect of GOS on fat metabolism, e.g., increased lipid 
oxidation.
SCFA are postulated to stimulate secretion of GLP-1 
in vitro, which in turn stimulates insulin secretion and 
inhibits gastric emptying and intestinal transit. However, 
it is unclear the degree to which this occurs in the colon. 
It has been suggested that the IM increases GLP-1 levels 
through production of SCFA [67]. This was confirmed with 
mono-colonization of genetically modified mice with two 
representatives of the IM, E. coli and B. thetaiotaomicron, 
with resulting lower and higher fermentation abilities, 
respectively and thus SCFA producing abilities [67]. The 
role of GLP-1 in decreasing small intestinal transit could be 
an adaptive response for promoting nutrient absorption in 
response to insufficient energy availability in the colon. Ele-
vated GLP-1 levels and slower intestinal transit times have 
also been reported in anorexia nervosa patients [68, 69], 
suggesting that this function may be conserved in humans. 
Even though the pre-meal plasma levels of GLP1-1 were 
less elevated compared to the standard diet, GOS has also 
been shown to increase (3.5 fold) the colonic mucosal gene 
expression of the GLP-1 precursor proglucagon [26]. Ana-
tomical and physiological factors might explain this, as a 
significant proportion of GLP-1 is produced in cells in the 
proximal parts of the small intestine, which receive minimal 
exposure to colonic GOS fermentation metabolites.
The effects of porphyran, a water-soluble dietary fibre 
from algal cell wall, were tested in a mouse model for type 
2 diabetes. Mice received a high-fat diet (14% fat), 5% por-
phyrin, or two kinds of porphyrin salt with 5% cellulose as 
control [63]. Besides improvements in plasma insulin lev-
els, insulin resistance index, and plasma adiponectin levels, 
changes in caecal SCFA content and IM composition were 
measured by gas chromatography and real-time PCR. The 
content of caecal propionate was significantly higher when 
porphyrin was fed. SCFA are ligands for the G protein-
coupled receptors GPCR41 and GPCR43 and may impact 
adipocytokine production. Interestingly, the increase of pro-
pionate was not significant when the porphyrin salts were 
fed, suggesting that arginine and potassium might influence 
the metabolism of the caecal microbiota. In all porphyrin 
groups, higher numbers of Bacteroides spp. and fewer C. 
coccoides were detected in the caecum compared to controls 
[63].
Neyrinck et al. [66] found that intake of chitin–glucan 
fibre can partly reverse the impact of a high-fat diet on 
the IM in animals. Mice received a high-fat diet (60% fat, 
20% carbohydrates, and 20% proteins) or a high-fat diet 
supplemented with 10% fungal chitin–glucan for 28 days. 
The high fat diet decreased total bacteria number in caecal 
samples and in particular Bacteroides/Prevotella group, C. 
coccoides/E. rectale cluster, Lactobacillus spp., and Rose-
buria spp. Bifidobacteria were increased and suggest that the 
effect may depend on the composition of the high-fat diet. 
With the addition of the chitin–glucan fibre, the high-fat diet 
induced decrease in the C. coccoides/E. rectale cluster and 
Roseburia spp. was partly compensated by a modest increase 
in number of Bacteroides/Prevotella group. In addition, the 
high-fat induced body weight gain, fat mass development, 
plasma cholesterol concentration, hepatic triglycerides, and 
other metabolic markers were also counteracted.
The impact of oligofructose consumption in genetic or 
diet-induced obese and diabetic mice has been studied [57, 
58]. In contrast to the human trial [51], a decrease in the 
caecal abundance of the Firmicutes, but increase in Bacte-
roidetes as measured by pyrosequencing was reported [58]. 
Similar to the human study, at the genus level, significant 
increases were found for Bifidobacterium spp. by quantita-
tive PCR. In both animal trials, caecal Roseburia spp. were 
found to be decreased. The authors concluded that modi-
fication of the IM by oligofructose leads to improvement 
of glucose homeostasis and leptin sensitivity and targets 
enteroendocrine cell activity in obese diabetic mice. Inter-
estingly, positive associations were found between Anaer-
otruncus and glucose intolerance, intestinal permeability, 
plasma triglyceride content, and lipid muscle content and 
 Eur J Nutr
1 3
between Clostridium lactifermentas and glucose intolerance, 
intestinal permeability, and lipid muscle content, and finally 
between Streptococcus intermedius and intestinal permeabil-
ity. Others [57] have shown that oligofructose consumption 
counteracted the increase in GPR43 over-expression induced 
in the adipose tissue by a high-fat diet. GPR43 is a key factor 
controlling adipose differentiation leading to the accumula-
tion of large adipocytes upon a high-fat diet. Interestingly, 
De Vadder et al. [56] identified another mechanism by which 
FOS can exert their effects. FOS supplementation signifi-
cantly decreased colonic levels of Firmicutes while increas-
ing levels of Bacteroidetes in mice. These changes correlated 
with significant increases of propionate in the portal vein 
which led to activation of intestinal gluconeogenesis and, 
as such, induced beneficial effects on glucose and energy 
homeostasis.
Oat bran supplemented to an atherogenic diet for 4 weeks 
showed a significant increase in the total bacterial abun-
dance and more specifically in the caecal abundance of B. 
fragilis and Akkermansia in two sub-strains of C57BL/6J 
mice in comparison with the controls. In addition, one of the 
sub-strains showed a significant decrease in plasma choles-
terol and plasma fructosamine levels, a significant increase 
in faecal secretion of bile acids as well as an increase in 
the hepatic expression of enzymes in the bile acid syn-
thesis pathways CYP7A1 and CYP8B1. However, a cor-
relation between the changes in the microbial community 
and the cholesterol lowering properties of oat bran was not 
observed [53]. In another study, blueberry husks were added 
to a control diet (120 g dietary fibre/kg diet) and fed to rats 
for 5 days [54]. The rats consuming the diet with blueberry 
husks gained significantly more weight than the rats con-
suming the control diet. In addition, the faecal wet weight 
was significantly increased. Some 39% of the ingested die-
tary polysaccharides from the blueberry husks were excreted 
which was suggested to be due to the high lignin content. 
The caecal counts of lactobacilli, bifidobacteria, and Entero-
bacteriaceae significantly decreased, while the total SCFA 
content in the caecum, distal colon, and faeces of the rats 
was significantly higher for the blueberry husks diet- than 
the control diet-fed rats. In the caecum, significantly higher 
levels of acetic acid and l-lactate were found, while propi-
onate and minor acids were significantly decreased. In the 
distal part of the colon and in the faeces significantly, higher 
proportions of propionate and butyrate, respectively, were 
found, with blueberry husks consumption [54]. It has been 
suggested that the effects may be due to the anti-microbial 
action of the phenolic compounds in the blubbery husks, in 
addition to the fibre.
Hydroxypropyl methylcellulose, a synthetic modifica-
tion of the natural polymer cellulose, supplemented at 10% 
(w/w) to a high-fat diet for 4 weeks was found to signifi-
cantly increase the levels of faecal Erysipelotrichaceae and 
faecal and caecal Peptostreptococcaceae while decreasing 
the abundance of faecal Lachnospiraceae and faecal and 
caecal Ruminococcaceae in high-fat diet-fed mice as meas-
ured by pyrosequencing. At the genus level, hydroxypropyl 
methylcellulose led to significant decreases in Johnsonella 
and Lactobacillus and significant increases in E. incer-
tae Sedis and Peptostreptococcus. In addition, metabolic 
changes were found upon hydroxypropyl methylcellulose 
consumption, i.e., significantly reduced total cholesterol, 
high, low, and very low density lipoprotein cholesterol, 
leptin, liver triglycerides, and liver percentage adiposity. In 
contrast, the product significantly increased levels of faecal 
saturated, unsaturated, and trans-saturated fat, monoacyl-
glycerides/free fatty acids, bile acids, and energy. Positive 
associations between weight changes and faecal saturated 
fat were found for caecal Erysipelotrichaceae and caecal 
Erysipelotrichales, respectively. Faecal abundances of Lach-
nospiraceae were negatively correlated with energy intake 
and caecal Porphyromonadaceae correlated positively with 
liver-free cholesterol [55]. The impact of polydextrose sup-
plementation (30 g/day for 3 weeks) on the IM composition 
and activity, and immunological parameters was investigated 
in 20 healthy pigs fed a high-energy-density diet [59]. Poly-
dextrose was found to be fermented at an even rate along the 
intestine and about 66% of the amount present in the distal 
small intestine was recovered at the distal part of the colon. 
Levels of faecal SCFA and tryptamine were significantly 
decreased in the distal colon upon polydextrose supplemen-
tation, while spermidine and spermine were significantly 
increased. A tendency towards a decreased expression of 
mucosal cyclo-oxygenase-2 was reported. No significant 
changes in the composition of the IM community as meas-
ured by % G + C profiling and FISH were observed [59].
While investigating the effects of eight different dietary 
fibre containing diets on metabolic risk factors, changes 
in the formation of SCFA and the caecal microbiota were 
measured [61]. Either a low-fat diet (50 g fat/kg) or a high 
fat diet (280 g fat/kg) containing either, no fibre, pectin, guar 
gum, or a pectin-guar gum mixture was fed to rats for 2 or 
6 weeks, respectively. In general, the high-fat diet reduced 
the butyrate concentration (in blood, serum, and caecal sam-
ples) and increased the succinate caecal levels significantly 
after 2 weeks. Butyrate and succinate were generally higher 
in all groups that received fibres in comparison with the 
groups on the fibre-free diet. The amount of total SCFA in 
blood serum and the caecum was lowered by diets without 
fibre, with pectin or with guar gum reduced, but not with 
the mixture of fibres. This has also been shown in the pre-
vious studies, suggesting that this is due to a change in the 
IM. Among the high-fat groups, all fibre interventions led 
to a higher serum content of acetate in comparison with the 
fibre-free intervention. Interestingly, guar gum and the mix-
ture of fibres counteracted the effect of the high-fat induced 
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decrease of butyrate. In addition, the IM composition ana-
lysed from caecal samples changed considerably in response 
to each dietary fibre diet. Rats fed guar gum showed higher 
numbers of Bacteroides, which relates to butyrate levels in 
the serum and caecum as well as caecal propionate levels. 
The fibre-free diet led to an increase of Akkermansia in the 
caecum. For the pectin group, high individual variation 
was detected and no distinct IM changes could be identi-
fied, but an increased formation of acetate was noted. In 
addition, in this study, it was also shown that dietary fibres 
reduced weight gain, lowered the amount of liver fat, hepatic 
cholesterol, and triglycerides, and decreased inflammatory 
markers. Pectin and the mixture of fibres seemed to have the 
strongest impact [61].
Impact of the intestinal microbiota on the metabolism 
of resistant starch
While the majority of dietary starch ingested is completely 
digested, a small proportion, known as RS, escapes digestion 
in the small intestine and reaches the colon. RS is classified 
into four types of starch, physically inaccessible forms, and 
certain granular forms that are resistant to enzyme diges-
tion, retrograded, and chemically modified starch. RS pro-
vides the colonic bacteria with the largest single-source of 
diet-derived energy. Seven publications relating to RS were 
identified. Of these, two reported studies in humans [70, 71] 
and five in animals [24, 32, 72–74]. The number of human 
subjects per study varied from 14 to 46 and study duration 
varied from 3 to 4 weeks.
Data from human studies on resistant starch
A randomized cross-over trial including 46 healthy adults 
[70], showed different responses of the microbial commu-
nities to a 4-week diet high in non-starch polysaccharide 
(NSP in the form of ‘added wheat fibre’) (25 g total fibre 
and 1 g RS) or high in NSP and RS (25 g total fibre and 
22 g RS). A significant increase in the abundance of faecal 
R. bromii was observed in the case of the NSP plus RS diet. 
In addition, faecal total SCFA, acetate, and butyrate levels 
were significantly increased upon consumption of the NSP 
plus RS diets and the stool pH significantly decreased. The 
impact of diets rich in RS or NSP on the IM in an obese 
population has also been investigated [71]. Fourteen obese 
men with metabolic syndrome participated in a 10-week 
intervention trial consuming four different diets: a run-in 
maintenance diet for 1 week; a crossover of two diets each 
for 3 weeks, one diet high in RS type-3 and one diet high in 
NSP; and finally, a weight-loss diet with high protein and 
medium carbohydrate levels. Human Intestinal Tract Chip 
analyses of the faecal microbial communities showed a sub-
jectwise clustering indicating a strong individuality of the 
microbial community structure and relatively limited effects 
of the diets. Overall, the impact of the diet explained about 
10% of the total variance in IM composition. However, 
comparison of the IM composition on an individual basis 
did show significant differences between the diets. RS was 
found to stimulate mainly bacteria belonging to Clostridium 
cluster IV such as O. guillermondii and R. bromii, while 
bacteria belonging to Clostridium cluster XIVa decreased. 
The NSP diet was found to stimulate the growth of bacteria 
belonging to the family Lachnospiraceae. Faecal SCFA were 
found to be significantly lower on the RS and weight-loss 
diet in comparison with the NSP and maintenance diets. 
Interestingly, propionate production was positively corre-
lated with faecal Bacteroidetes abundance, and in addition, 
a positive correlation was found between faecal bifidobac-
teria and plasma insulin. Remarkably, the responsiveness 
of an individual’s IM to a dietary intervention, either RS or 
NSP or weight loss, was found to be dependent on the initial 
microbial diversity of the individual. Those with a low initial 
microbial diversity were identified as so-called ‘responders’ 
versus individuals with a high initial microbial diversity or 
so-called ‘non-responders’. The authors indicated that this 
result was consistent with the concept that phylogenetic 
diversity promotes ecosystem stability.
Data from animal studies on resistant starch
Further insights into the impact of RS consumption on the 
IM and host metabolism have been generated in animal tri-
als. Rats fed potato-RS diets with casein or cooked beef 
showed increased abundance of Bifidobacterium in the cae-
cum and both Bifidobacterium and Lactobacillus in the colon 
as revealed by quantitative PCR [24]. A significant increase 
in acetate was found in comparison with a cellulose diet. 
No decrease in markers of proteolytic fermentation, phenol, 
and p-cresol was found, although longer colon crypts and a 
greater number of goblet cells per crypt were found upon RS 
feeding indicating improved colonic health. In pregnant rats 
fed RS type 2 (high-amylose maize starch), an improvement 
of insulin sensitivity and glycaemic control was shown in 
comparison with rats fed an equal energy dense control diet 
[32]. In addition, pups born to rats on the RS diet had lower 
fasting glucose levels. Caecal and faecal pH were found to 
be significantly decreased, caecal SCFA levels significantly 
increased, and Bacteroides, Bifidobacterium, Lactobacil-
lus, and Clostridium cluster IV populations significantly 
increased in the RS-fed adult rats after weaning. In addi-
tion, β-cell relative densities were significantly decreased 
and serum total GLP-1 levels significantly increased. The 
latter was suggested to result from the increased produc-
tion of butyrate and linked to the mechanism of improved 
glycaemic control. Similarly, significantly higher caecal 
propionate and plasma GLP-1 levels as well as significantly 
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decreased liver triacylglycerides were reported upon con-
sumption of RS type-2 or hydroxypropylated RS type-2 in 
rats [73]. According to the human study results, an increase 
in faecal R. bromii and propionate levels in the distal colonic 
digesta was found in azoxymethane-treated rats (a model for 
colorectal cancer) consuming a diet supplemented with RS 
type-2 for 31 weeks. Consumption of butylated RS type-2 
was also shown to increase propionate and butyrate levels in 
the distal colonic digest and faecal levels of L. gasseri and P. 
distasonis [72]. In the same model, Le Leu et al. [74] showed 
a significant increase in the caecal and colonic total SCFA 
levels, as well as propionate and butyrate levels upon RS 
type-2 consumption. A non-significant trend towards protec-
tion against colorectal cancer was observed.
In summary, few recent studies have investigated the 
impact of specific IM clusters on the metabolism of vari-
ous fibres or RS. Most intervention studies deal with the 
question of how fibre and RS change the IM composition. 
Such results give rather indirect information on which IM 
might be involved in the degradation processes. More stud-
ies are needed to clarify which IM composition results in an 
improved availability of various fibres and RS for the host. 
In addition, monitoring of the production of metabolites in 
a more precise manner is required to obtain better insights 
into the specific metabolic pathways and microbial species 
involved. In relation with dietary fibre, studies have associ-
ated increased microbial richness with diets high in fibre, 
vegetables, and fruits. In controlled human studies, consist-
ent data exist that show a correlation between the intake of 
fibre and an increase in bifidobacteria and SCFA, in particu-
lar butyrate. This leads to lower pH values in the intestinal 
tract, which is considered beneficial. Regarding changes in 
the composition of the faecal microbiota, there are conflict-
ing data or data that require more detailed examination of 
the bacteria at species level; e.g., in one study, bacteroides in 
general were increased after fibre supplementation, whereas 
other studies revealed a decrease in Bacteroides intestinalis 
and Bacteroides vulgatus. Overall, fibre intake and its effects 
on metabolites and IM composition were associated with a 
positive impact on glucose and fat metabolism in humans.
Impact of the intestinal microbiota on the metabolism 
of polyphenols
Polyphenols are a large class of structurally diverse chemi-
cals found in plants that can be separated into three main 
subclasses, the phenolic acids (derivatives of benzoic acid 
and cinnamic acid), stilbenoids (stilbenes), and the flavo-
noids. The flavonoids are further sub-divided into the fla-
vonols, flavones, isoflavones, flavanones, anthocyanidins, 
and flavanols (flavan-3-ols). The majority of these poly-
phenols, particularly the flavonoids, occur naturally in their 
glycosylated form (conjugated to a sugar moiety). In their 
glycosylated and polymeric forms, these polyphenols are 
usually poorly absorbed in the upper gut and pass into the 
large intestine, where they become substrates for the IM. 
Glycosides can be cleaved to liberate the aglycone and com-
plex structures can be broken down into their monomeric 
forms which improve bioavailability and alter bioactivity. 
Although host intestinal mucosal enzymes can hydroxylate 
some glycosides, the majority are metabolized by enzymes 
derived from the IM. In vivo studies evaluating the influ-
ence of the IM on polyphenol metabolism, and subsequent 
bioavailability, in both animals and humans are summarized 
below. The screening approach used identified three human 
[75–77] and five animal [78–82] studies that met the selec-
tion criteria for assessing the interaction between the IM 
and polyphenols excluding isoflavones. Several studies have 
characterized the microbial biotransformation of polyphe-
nols using in vitro culture systems. However, the focus for 
this review was specifically on in vivo studies. The num-
ber of subjects in the human studies varied from two to 35 
and the study duration varied from single dose to 17 day 
follow-up.
Data from human studies on polyphenols
The IM is known to metabolize polyphenols into smaller 
metabolites through a range of biotransformational strategies 
including dehydroxylation, deglycosylation, and demethyla-
tion. In a human study [76], the microbial metabolism of 
almond skin polyphenols (884 mg total polyphenols/dose) 
was characterized in urine and blood using a liquid chroma-
tography–mass spectrometry (LC–MS) approach. Despite 
the limited sample size of this study (n = 2), several micro-
bial metabolites were detected including hydroxyphenyl-
valerolactones, 5-(dihydroxyphenyl)-γ-valerolactone, and 
5-(hydroxymethoxyphenyl)-γ-valerolactone. These com-
pounds arise from the microbial degradation of flavanols and 
were detected in their glucuronidated and sulfated forms. 
Through fission of the valerolactone ring, the IM can further 
metabolize these products to the hydroxyphenylvaleric acids. 
These compounds are subsequently broken down via bacte-
rial β-oxidation to produce hydroxyphenylpropionic acids 
(3,4-dihydroxyphenylpropionic acid and 3-hydroxyphenyl-
propionic acid) and hydroxybenzoic acids (3-hydroxyben-
zoic acid, 4-hydroxybenzoic acid, protocatechuic acid, and 
vanillic acid). Additional processing of hydroxyphenylpro-
pionic acids can occur through α-oxidation to hydroxyphe-
nylacetic acids (3,4-dihydroxyphenylacetic acid, 3-hydroxy-
phenylacetic acid, 4-hydroxy-3-methoxyphenylacetic acid, 
and phenylacetic acid). All of these microbial metabolites 
were observed to increase in the urine post-almond poly-
phenol intake [76]. In addition, 4-hydroxyhippurate, m- and 
p-coumaric acids, ferulic acid, and 4-hydroxy-3-methoxy-
phenylacetic acid were measured in the urine and plasma 
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post polyphenol intake. 4-Hydroxyhippuric acid is formed 
from the hepatic conjugation of 4-hydroxybenzoic acid 
with glycine. The hydroxycinnamic acids, m- and p-cou-
maric acid, are formed from the dehydrogenation of 3- and 
4-hydroxypropionic acids, respectively, and further para-
hydroxylation and methylation of m-coumaric acid results 
in ferulic acid. Methylation of protocatechuic acid and 3, 
4-dihydroxyphenylacetic acid produces vanillic acid and 
4-hydroxy-3-methoxyphenylacetic acid, respectively. Col-
lectively, these findings demonstrate the importance of IM 
metabolism of polymerized polyphenols and the diverse bio-
transformation possibilities encoded in the microbiome and 
their resultant metabolic outputs.
The IM metabolism of flavanols with different degrees 
of polymerization was studied in six healthy men using a 
randomized cross-over study design [77]. These flavanols 
included epicatechin (monomer), procyanidin B1 (dimer), 
and a purified polymeric procyanidin fraction isolated from 
cocoa. Both gas chromatography (GC) and LC–MS plat-
forms were used to measure metabolites in urine, blood, 
and faeces. In these individuals, the IM metabolized the 
monomeric and dimeric flavanols to products that are 
absorbed from the intestinal tract. These metabolites 
were 5-(3,4-dihydroxyphenyl)-valerolactone (DHPV) 
and 4-hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 
(4H-DHPVA). E. lenta has been shown in vitro to perform 
the reductive cleavage of (−)-epicatechin and (+)-catechin to 
1-(3,4-dihydroxyphenyl)-3-(2,4,6-trihydroxyphenyl)propan-
2-ol, which can then be metabolized by Flavonifractor plau-
tii to DHPV and 4H-DPVA [98]. High plasma and urinary 
excretion of DHPV following flavanol ingestion indicates 
that a large amount of epicatechin and the vast majority of 
procyanidin B1 is metabolized by the IM, with plasma con-
centrations peaking 8 h post-intervention. This indicates that 
flavanols are absorbed in either their monomeric form or the 
microbial breakdown product DHPV. In contrast, the same 
trends were not observed with the larger polymers contained 
in the cocoa-derived procyanidin extracts [77]. This implies 
that the IM cannot metabolize these complex flavanols with 
the same efficiency as the simpler molecules. Indeed, the 
degree of polymerization appears to be inversely associated 
with the production of DHPV. The large structure of these 
compounds is likely to impede uptake into the bacterial cell 
restricting their breakdown. A high degree of variation was 
noted across individuals in the formation of DHPV mostly 
likely attributable to functional variation in the IM across 
participants.
A metabolomic approach was applied to assess the poten-
tial for polyphenols to counteract inflammation and oxidative 
stress that can occur with intense exercise [75]. Water-solu-
ble polyphenols from blueberry and green tea extracts were 
provided to long-distance runners (n = 35) before intense 
exercise and alterations in the metabolic composition of 
their blood was evaluated. This supplement was rich in phe-
nolic compounds (2136 mg gallic acid equivalents) includ-
ing flavanols, such as anthocyanins and catechins, several 
hydroxycinnamic acids, and flavonol glycosides of quercetin, 
kaempferol, and myricetin. While the supplement was not 
found to alter inflammation or oxidative stress post-exercise, 
a range of metabolites associated with the bacterial break-
down of phenolic compounds were increased post-exercise 
including hippurate, 4-hydroxyhippurate, 4-methylcatechol 
sulfate, and cinnamoylglycine. Circulating arabinose, a pen-
tose sugar associated with blueberry anthocyanins, was also 
increased in these individuals arising from the bacterial deg-
radation of these flavanols. Interestingly, exercise increased 
intestinal permeability in these individuals, increasing host 
exposure to these IM-derived metabolites. As with the pre-
vious study investigating flavanol metabolism [77], a large 
amount of variation was also observed in the circulating 
amounts of these microbial metabolites across the partici-
pants, again most likely reflecting functional variation in the 
IM. Although the microbial breakdown products of these 
dietary polyphenols are considered to have lower antioxi-
dant and anti-inflammatory properties than their parent 
compounds, the enhanced bioavailability of these deriva-
tives may compensate for this reduction in bioactivity [99].
Data from animal studies on polyphenols
The participation of the IM in the metabolism and bioavail-
ability of polyphenols was also demonstrated in several 
rodent studies. Baicalin is a flavone found in Scutellaria 
baicalensis Georgi that is used in traditional herbal medi-
cine. It is a biologically active compound that is hydrolysed 
by bacterial β-glucuronidases in the intestinal tract to the 
aglycone, and more readily absorbable form, baicalein [100]. 
Once absorbed baicalein is glucuronidated, in both the liver 
and intestine, back to baicalin (baicalein-7-glucuronide) 
and other glucuronide conjugates such as baicalein-6-glu-
curonide. The importance of the IM in baicalin metabolism 
was demonstrated by the significant effect on the pharma-
cokinetic profile of orally administered baicalin observed 
in rats after antibiotic pre-treatment [79]. The persistence 
of baicalin in the intestinal contents of rats receiving the 
antibiotics highlighted the inability of the host to perform 
this function. This demonstrates the crucial role of the IM in 
determining the pharmacokinetics of this flavonoid and the 
extension of the metabolic functionality of the host beyond 
that encoded within the genome. The bioavailability of all 
flavonoids, however, was not influenced by the IM. Others 
[80] have found that the IM had minimal influence on the 
absorption of the flavones luteolin and apigenin. Here, rats 
were provided with a Chrysanthemum morifolium Ramat 
extract (200 mg/kg) containing luteolin and apigenin in their 
glycosylated forms. Flavone deglycosylation was high in the 
 Eur J Nutr
1 3
large intestine with a good recovery (70%) of luteolin and 
apigenin in the caecum and colon of the rats. However, a 
significant amount of flavone deglycosylation occurred in 
the rat stomach and small intestine resulting in rapid absorp-
tion. As such, the contribution of the IM towards the bio-
availability of these flavonoids was negligible. This was 
confirmed in subsequent experiments administering either 
antibiotics or emptying the luminal contents of the intestine 
to minimize the metabolic contribution of the IM. The for-
mation of aglycones was not significantly reduced in these 
experiments indicating that intestinal glycosidases were the 
primary contributors to this action. This is consistent with 
an earlier study that measured the metabolism of luteolin, 
apigenin, and their conjugates in GF rats [101].
Quercetin glycosides are the most abundant flavonoids 
in fruits and vegetables and the importance of the IM in 
their metabolism was demonstrated in the rat [81]. Although 
host mechanisms exist for the metabolism and uptake of 
these compounds in the small intestine, their bioavailabil-
ity is considered to be poor. Consequently, a large amount 
of flavonoids reach the colonic microbiota which, in turn, 
hydrolyse the sugar moiety and release the aglycone facili-
tating the absorption of the flavonoids. However, extensive 
microbial processing of the quercetin aglycone to 3,4-dihy-
droxyphenylacetic acid and phloroglucinol can occur reduc-
ing its bioavailability and bioactivity [102]. In this study, 
the authors established that supplementing rats with either 
the non-digestible disaccharide, di-d-fructose anhydride III 
(DFAIII), or FOS attenuated the microbial breakdown of the 
quercetin aglycone. Decreasing this breakdown promoted 
quercetin availability, increasing systemic levels of querce-
tin derivatives and their urinary excretion. Faecal excretion 
of quercetin metabolites, mainly methylquercetin, was also 
increased in animals provided with DFAIII and FOS. In 
total, the urinary and faecal excretion of the aglycone was 
30% that of the ingested amount in rats fed FOS or DFAIII. 
In the control animals, a total of 16.4% of the aglycone was 
excreted, suggesting that almost 85% of the quercetin agly-
cone was metabolized by the IM. Both DFAIII and FOS 
serve as fermentable substrates for the IM and these findings 
show that the provision of alternative microbial substrates 
can spare dietary components from microbial breakdown 
increasing their availability for uptake.
The antioxidant properties of polyphenols are suggested 
to prevent or reduce oxidative stress and, therefore, dam-
age, associated with ischemia–reperfusion (I/R) injury. A 
mouse study [78] explored the potential for chokeberries 
and bilberries, rich in anthocyanins to reduce the oxida-
tive stress caused by I/R. Anthocyanins are effective anti-
oxidants and are metabolized by the colonic microbiota to 
absorbable derivatives of phenylpropionic, phenylacetic, 
and benzoic acids of various different hydroxylation 
patterns. Following intake of the polyphenol-rich diet, 
various microbial degradation products of the polyphenols 
were detected in the caecum and colon of the mice. In the 
bilberry-supplemented mice, 3,4-dihydroxyphenylacetic 
acid, a gut bacterial metabolite of proanthocyanidin and 
quercetin (both known to be present in bilberries), was 
observed in the large intestine. 3-Hydroxyphenylpropionic 
acid was also found in the caecum and colon of these ani-
mals. This metabolite is considered to derive from the bac-
terial action on epicatechin, catechin, procyanidins, and 
chlorogenic acid. In the chokeberry-fed mice, dehydroxy-
lation products of 3,4-dihydroxyphenylacetic acid (3- and 
4-hydroxyphenylacetic acid) were measured in the caecum 
and colon. Many of these aromatic acid metabolites gener-
ated by the IM possess antioxidant properties and as they 
are more readily absorbed than their parent compounds, 
these biotransformations are considered important in rela-
tion with the protective effect of polyphenols, and poly-
phenol-rich foods, against oxidative stress. Interestingly, 
bilberries, but not chokeberries, were found to reduce 
tissue injury associated with I/R. Chokeberries contain a 
greater amount of highly polymerized procyanidins and 
this may underlie the reduced antioxidant properties and 
effectiveness of chokeberries compared to bilberries as the 
greater degree of polymerization restricts bacterial access 
for degradation. This is consistent with the observations 
for flavanols in humans [77]. Another contributing factor 
may be the greater diversity and complexity of the antho-
cyanins in the bilberries that survive transit into the colon 
compared to chokeberries.
Given the therapeutic interest in grape seed polyphenol 
extract (GSPE) in Alzheimer’s disease, the role of the IM 
in shaping their bioavailability and bioactivity was deter-
mined in rats [82]. GSPE is rich in simple and complex 
phenolic compounds and the IM are known to metabolize 
these to more readily absorbable phenolic acids. Following 
oral administration of GSPE for 11 days, the bioavailability 
of 12 phenolic acids, produced from the bacterial metabo-
lism of anthocyanidins, were measured by high-pressure 
LC–MS. These compounds included ferulic acid, hippurate, 
3- and 4-hydroxybenzoic acid, 3- and 4-hydroxyhippurate, 
3-hydroxyphenylacetic acid, 3-(3,4-dihydroxyphenyl)acetic 
acid, 3-hydroxyphenylpropionic acid, 3-(3,4-dihydroxyphe-
nyl)propionic acid, 5-(4-hydroxyphenyl)valeric acid, and 
phenylacetic acid. GSPE intake was found to increase the 
accumulation of all 12 phenolic acids measured in the cae-
cum, colon, urine, and/or blood. Of these, two phenolic acids 
(3-hydroxybenzoic acid and 3-(3-hydroxyphenyl) propionic 
acid) were found to accumulate in the brain at micromolar 
concentrations. The metabolites were shown to potently dis-
rupt the formation of neurotoxic β-amyloid aggregates that 
have been implicated in Alzheimer’s disease pathogenesis. 
Thus, highlighting the potential role of IM-derived microbial 
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metabolites of polyphenols in brain physiology and health 
maintenance.
Overall, these in vivo studies demonstrate the strong 
influence of the IM on the bioavailability and bioactivity of 
a range of dietary polyphenols and their subsequent impact 
on the host. The extent of polyphenol biotransformation is 
largely dependent on structure and the degree of polymeriza-
tion. Presently, there are few in vivo studies exploring genus-
level associations with specific polyphenol processing traits 
with these investigations largely restricted to in vitro studies. 
Nevertheless, our understanding of the role of the IM in 
shaping the host visibility of polyphenols and their break-
down products is increasing, as are the methods that can be 
used to measure this, for example, strategies are evolving, 
such as prebiotic supplementation to manipulate the micro-
bial interactions to enhance the benefits for the host [103]. 
Given the growing health benefits associated with polyphe-
nols, optimizing such benefits via the IM is an attractive area 
of future research.
Impact of the intestinal microbiota on the metabolism 
of isoflavones
Isoflavones are naturally occurring plant substances that 
belong to the ‘phytoestrogen’ class and the effect of their 
intake is being studied in a range of hormone-dependent 
conditions. In relation with the metabolism of isoflavones, 
particularly daidzein, a total of 15 studies were identified 
that fulfilled the selection criteria. Of these, ten were human 
studies [83–92] and five were animal studies [93–97]. Num-
ber of subjects varied from 11 to 297 and study duration 
varied from single dose to 20 weeks follow-up.
Data from human studies on isoflavones
The majority of studies focussed on formation of the known 
daidzein metabolites dihydrodaidzein, equol and O-desmeth-
ylangolensin (ODMA) and on equol- or ODMA-phenotype 
determination. In a study in postmenopausal women, sup-
plemented with 160 mg isoflavones for 1 week, four of the 
14 subjects (~ 29%) were classified as equol producers with 
average urine equol concentrations of 2915 nM [88]. All 
14 subjects were considered ODMA producers, although 
urine concentrations varied widely. Similarly, others used 
a 3-day soy challenge (either providing ~ 83 mg/day daid-
zein or ~ 3 mg daidzein/day) to phenotype 297 obese, over-
weight, and normal weight individuals [86]. Around 80% of 
the subjects were ODMA producers and ~ 42% were equol 
producers. Obese individuals were 2.8-times more likely to 
be ODMA-non-producers. Teas et al. [91] also identified 
five of 17 (~ 29%) postmenopausal women as equol pro-
ducers when subjects consumed a daily soy protein isolate 
(2 mg isoflavone/kg body weight) for 1 week in addition 
to placebo or seaweed (which subjects had received for 
the entire 7-week study period). Urinary equol excretion 
was enhanced when the soy protein isolate was consumed 
in combination with 5 g/day seaweed. In a study popula-
tion of 36 young women, it was found that 26% had the 
equol−ODMA−phenotype, 58% equol−ODMA+, 9% 
equol+ODMA−, and 12% equol+ODMA+ phenotypes 
[84]. In phase I of this study, a soy protein formula was con-
sumed with over 90% conjugated isoflavones (45% genistin, 
40% daidzin, and 6% glycetin) equivalent to aglycone sup-
plementation of 40 mg genistein and 20 mg daidzein daily 
for 4 weeks. Urinary daidzein, genistein, equol, and ODMA 
concentrations were measured to determine phenotype. In 
phase II of the same study, subjects were co-supplemented 
with Lactobacillus GG (2 × 1010 cfu) for 4 weeks, and this 
appeared to reduce total and individual isoflavone excretion 
by 40% either through enhancement of isoflavone deconju-
gation and/or blocking degradation of daidzein and genistein 
[84]. The stability of the equol and ODMA phenotypes over 
time has also been studied [85]. Phenotypes were determined 
by analysing equol and ODMA in urine following 3-day soya 
supplementation (one soy food item per day in addition to 
their normal diets) at two time points (T1 and T2) that were 
1–3 years apart. 41% of the 92 subjects were equol produc-
ers at T1 and 45% equol producers at T2 and 90% were 
ODMA producers at T1 and 95% at T2. Concordance of 
phenotype was 82% for equol-producer phenotype and 89% 
for ODMA-producer phenotype. How long-term dietary 
habits affect soy isoflavone metabolism has also been stud-
ied [87] by comparing the plasma and prostatic fluid levels 
of genistein, daidzein, equol, dihydrodaidzein, and ODMA 
of healthy men who were considered long-term high soy 
consumers (30 mg or more soy isoflavones/day for at least 
2 years) with those who were long-term low soy consum-
ers (5 mg or less soy isoflavones/day for at least 2 years) at 
baseline and after an intervention with a soy beverage for 
1 week providing between 42 and 60 mg isoflavones/serv-
ing (43% daidzein, 53% genistein, and 4% glycitein). Equol 
was the only metabolite affected by routine dietary habits 
and men who had consumed more than 30 mg isoflavones 
per day had 2.8 times the probability of producing equol 
compared to men consuming low levels of soy (28% equol 
producers compared to 10%). This difference was more pro-
nounced when groups were further sub-divided into very 
high soy consumers (more than 50 mg/day of isoflavones). 
Meat consumers also appeared to be more likely to pro-
duce equol [87]. A pharmacokinetic study supplemented 11 
healthy postmenopausal women with a capsule containing a 
isoflavone-rich soy extract (1 mg/kg bw calculated as isofla-
vone daidzein and genistein aglycone equivalents) measured 
genistein, daidzein, and various metabolites, including five 
microbial metabolites (dihydrodaidzein, dihydrogenistein, 
ODMA, 6′OH-ODMA, and equol) as well as two conjugated 
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microbial metabolites (equol-4′sulfate and equol-7-glucuro-
nide) [90]. Apart from equol, all of the microbial metabolites 
were detected in plasma and urine including the conjugates 
of equol. A study in Japanese postmenopausal women con-
suming a soy isoflavone supplement investigated the effects 
of short-term FOS intake on equol production [92]. Subjects 
were divided into equol- and non-equol producers and then 
assigned to groups consuming 37 mg isoflavone conjugate 
in capsule + 5 g sucrose as control or 37 mg isoflavone con-
jugate in capsule + 5 g FOS. FOS supplementation did not 
affect serum equol concentrations or urinary equol to daid-
zein concentration ratios [92]. Using a similar approach, the 
influence of inulin on plasma isoflavone concentrations in 
healthy postmenopausal women was studied using a cross-
over design [89]. Twelve women consumed 2 × 40 mg per 
day of conjugated soy isoflavones (6 mg daidzein and 18 mg 
genistein as aglycone) in period one and two times 40 mg per 
day of conjugated soy isoflavones (6 mg daidzein and 18 mg 
genistein as aglycone) plus 3.66 g inulin in period two. Each 
period lasted for 3 weeks. Plasma 24-h areas determined at 
the end of each experimental period indicated that inulin 
increased plasma concentrations of daidzein and genistein 
by 38 and 91%, respectively.
Only a limited number of studies analysed IM composi-
tion or changes per se after isoflavone consumption. Sup-
plementation with 160 mg isoflavones for 1 week in 17 
postmenopausal women resulted in an increase in average 
relative proportion of Bifidobacterium and decreases in Lac-
tobacillus and unclassified Clostridiaceae (analysed by 16S 
rRNA genes from 454 pyrosequencing). A comparison of 
subjects grouped into S-(−)equol and non-S-(−)equol pro-
ducers showed that Bifidobacterium, Rothia, other Bifido-
bacteriaceae, and other Actinobacteria were significantly 
higher in S-(−)equol producers whereas Roseburia was sig-
nificantly lower [88]. A total of 30 taxa significantly corre-
lated with one to three excreted isoflavone metabolites. The 
effects of isoflavones on IM composition were specifically 
investigated in a study involving 39 postmenopausal women. 
All subjects received a gelified milk and cereal bar together 
providing 100 mg/day of isoflavones aglycone equivalents. 
After 30 days, the subject were split into three groups with 
group one receiving 100 mg isoflavones/day aglycone equiv-
alent, group two receiving 100 mg isoflavones/day aglycone 
equivalent and B. animalis DN-173010  (109 cfu), and group 
three receiving 100 mg isoflavones/day aglycone equivalent 
and FOS (7 g/day). Isoflavones alone stimulated dominant 
microorganisms of the C. coccoides–E. rectale cluster, 
Lactobacillus–Enterococcus group, F. prausnitzii subgroup, 
and Bifidobacterium genus. The stimulation of the C. coc-
coides-E. rectale cluster (which includes the isoflavone-
metabolizing organisms Peptostreptococcus productus and 
E. ramulus) depended on the women’s equol excretion and 
was transient, with the exception of a prolonged bifidogenic 
effect. Lasting changes in the diversity of the dominant spe-
cies were also observed. Urinary equol production was not 
different in groups receiving pro- or prebiotics in addition 
to the isoflavones [83].
Data from animal studies on isoflavones
Ileal and faecal digestibility of daidzein and genistein and 
the extent of formation of metabolites in the intestinal tract 
in the ovariectomised rat, a model for postmenopausal 
bone loss, has been determined by measuring genistein, 
daidzein, and their metabolites in plasma, urine, faeces, 
and ileal digesta [94]. Ileal and faecal disappearance was 
monitored in two groups of rats that either consumed daid-
zein or genistein (0.026% of diet as aglycone; resulting in 
10.13 µmol input per 24 h) for 4 weeks. Ileal and faecal 
digestibility (disappearance) was significantly lower for 
daidzein than for genistein. Ileal disappearance of genistein 
was 93% indicating that only 7% passed into the colon. The 
majority of the genistein remaining in the intestinal tract was 
unmetabolised, but small amounts of the genistein metabo-
lite 4-ethylphenol were detected. Total digestive tract dis-
appearance of genistein was 99.9% of intake. Ileal digest-
ibility of daidzein was 32%, hence 68% of the total dietary 
intake passed into the colon. The daidzein metabolite equol 
was present in significant amounts in ileal digesta and was 
also the major metabolite excreted in faeces. Total digestive 
tract disappearance of daidzein was 77.5% of intake [94]. 
In the study by Poulsen et al. described above, equol was 
identified as the main daidzein metabolite in ileal digesta 
and faeces [94]. Both daidzein and equol were detected in 
plasma of the animals, but no dihydrodaidzein or ODMA. 
In urine, some dihydrodaidzein and 2-dehydro-ODMA were 
detected. On a mol/mol basis, 24-h total faecal and urinary 
excretion of daidzein and its known metabolites was 49.1%. 
4-Ethylphenol was the main genistein metabolite identified 
in faeces, plasma, and urine. Small amounts of dihydrogen-
istein and 4-(OH)-phenyl-2-propionic acid were detected in 
urine. Similarly, on a mol/mol basis, 24-h total excretion of 
genistein and its known metabolites was 41.7%. Excretion 
of both daidzein and genistein was largely through urine 
[94]. Pharmacokinetics of dietary daidzein (20 mg) and 
dietary racemic equol (4 mg) were studied in ovariecto-
mised rats [93]. Total unconjugated equol, free equol, equol 
monosulfate, and equol disulfate were measured in plasma 
and equol glucuronides were calculated. The maximum 
plasma concentration (Cmax) and time to reach it (tmax) for 
total equol were 8815 ± 2988 nmol/l and 2.17 ± 2.91 h and 
3682 ± 2675 nmol/l and 20.67 ± 4.67 h, for dietary equol 
and daidzein, respectively. Although the majority of equol 
metabolites present were glucuronide conjugates (≥ 99%), 
there were also low levels of equol monosulfate present [93].
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None of the identified animal studies investigated changes 
in the IM per se. However, several studies focussed on how 
other substrates modulate the IM, and, in turn, affect daid-
zein metabolism. Three studies in mice investigated how 
other dietary components such as xylitol, arabinose, or rice 
bran oil may change the gut microbial composition which, 
in turn, may also affect daidzein metabolism [95–97]. In all 
studies, two groups of mice were fed either 0.05% daidzein 
in the diet alone or together with 5% xylitol, 10% rice bran 
oil (in this case the daidzein group also received 10% lard as 
control) or 2.5% arabinose in their diets. It was demonstrated 
that xylitol, rice bran oil, or arabinose has the potential to 
affect the metabolism of daidzein by altering metabolic 
activity of the IM and/or the gut environment. Xylitol-fed 
mice had more urinary equol compared to controls and the 
abundance of Bacteroides was significantly greater in the 
control than in the xylitol group [97]. Mice fed rice bran 
oil in combination with daidzein had significantly lower 
urinary amounts of daidzein and dihydrodaidzein and the 
ratio of equol/daidzein was significantly higher compared 
to the control group. The abundance of Lactobacillales was 
significantly higher in the rice bran group [96]. l-Arabinose-
fed mice had lower urinary amounts of daidzein and the 
ratio of equol/daidzein was significantly compared to the 
control group. The abundance of Prevotella and Lactobacil-
lales were significantly lower in the arabinose group [95].
In conclusion, the effects of the IM on metabolism of 
daidzin/daidzein are well understood. Daidzin is converted 
to daidzein by bacterial β-glucosidases and the predomi-
nant metabolites produced by the human IM are equol and 
ODMA. Among humans, 30–50% have the bacteria capable 
of producing equol and 80–90% harbour ODMA-producing 
bacteria. To date, only a few equol-forming intestinal bacte-
ria have been identified and isolated from human faeces that 
harbour all the genes and express all the enzymes needed to 
convert daidzein to equol. However, several bacteria may 
work together in the metabolism of daidzein, and in vitro 
studies are often helpful to identify consortia of bacteria 
involved in the full metabolism of daidzein to equol and 
ODMA.
Conclusions
The IM is comprised of at least a trillion bacterial cells per 
gram of faeces and most of these bacteria can be classi-
fied into 400–800 individual species. These bacteria are in 
an intimate balance with the host as they facilitate energy 
and nutrient production, by digestion of food and de novo 
synthesis, degradation, and bioconversion of ingested 
compounds and homeostasis. How the IM exerts these 
effects is still incompletely understood but we are starting 
to gain a greater understanding through the use of modern 
culture-independent sequencing approaches and more under-
standing of the broad functional activities of the IM. How-
ever, despite recent advances in methodologies, it is clear 
from the systematic review that there have been limited 
recent human studies specifically evaluating effects of IM 
on breakdown, absorption, and metabolism of the selected 
ingested dietary components with the exception of inves-
tigations on various fibres and polyphenolic compounds. 
Considerable data exist on the effect of ingested dietary 
substrates on changes in the IM composition per se and in 
relation with metabolism of dietary substrates using animal 
models (pigs, rats, mice, dogs, rabbits, kittens). However, 
care must be taken in extrapolating results to humans due to 
the inherent physiological and metabolic differences (com-
position of the indigenous IM, transit time, caecotrophy). 
Nevertheless, when taken together recent data suggest that 
the IM composition and related activity in response to vari-
ous dietary substrates can have a significant effect on host 
physiology and that manipulation of the composition of 
the IM, particularly increasing the abundance of targeted 
groups, holds promise in relation with host health.
The IM has coevolved with the human host to perform 
functions that the host would not be able to accomplish 
alone. It extends the host’s metabolic capacity through, for 
example, substrate hydrolysis, reduction, methylation, dem-
ethylation, nitrosation, and deamination. It is evident that it 
can play a role in energy homeostasis. However, while dif-
ferences between genera and species were noted in relation 
with effects on energy homeostasis, changes in phylogeny 
classification make it difficult to draw conclusions. Care has 
also to be taken regarding the usefulness or even relevance 
of describing the IM at the phylum level, since the “biology” 
and certainly most host IM interactions occur at the spe-
cies/strain level. Furthermore, while faecal SCFA concen-
trations are widely reported, these values are the end result 
of a dynamic process involving production and absorption, 
and therefore, it is difficult to draw conclusions without more 
dynamic markers. In addition, interpretation of changes in 
SCFA production in relation with changes in “energy avail-
ability” do not take into consideration a major physiological 
role of SCFA produced during gut fermentation, i.e., regu-
lation of energy intake by inducing incretins, e.g., GLP-1 
which reduces food and energy intake. Therefore, the more 
SCFA are produced, the less energy is ingested, and less 
energy becomes available. Further studies are warranted 
that examine and differentiate energy produced by the IM 
via SCFA from the systemic effects of SCFA in regulat-
ing whole body or host-level energy intake and effects on 
energy homeostasis. Going forward, we need to apply better 
and more refined tools to more defined questions to make 
sense of diet–IM interactions in relation with energy bal-
ance. In particular, we need to ensure full characterisation 
of the test substrates, and methodological techniques used 
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to characterise the IM and their metabolites to allow com-
parison of results across studies.
Microbial breakdown and fermentation of proteins pro-
duce ammonia, amines, phenols, and BCFA. From the lim-
ited literature retrieved in relation to high-protein intakes, 
it was interesting to see a greater diversity in the microbes 
present in the intestinal tract and higher proportion of rare 
genera. In general, there was an increase in Bacteroides, 
Fusobacterium, Proteobacteria, especially Desulfovibrio (B. 
wadsworthia) and A. putredinis and of Bacteroides sp. Inter-
estingly, observed increases in A. putredinis and Bacteroides 
sp. correlated with higher concentrations of BCFA. Despite 
a global decrease in Firmicutes, Clostridium, Eubacterium 
and Ruminococcus were shown to increase with protein 
intake and Megasphera, Selenomonas, and Acidaminococcus 
decreased. Similarly, Prevotella, Archaea, and Bifidobacte-
rium appear to reduce. High-protein diets tend to lead to a 
decrease in the total SCFA production, while valerate and 
BCFA concentrations are increased. Some studies have also 
shown increased concentrations of secondary metabolites 
of bile acids, particularly of DCA and higher amounts of 
ammonia with high-protein intakes. An inverse relationship 
between Prevotella and Bacteroides has previously been 
reported in studies examining high-protein diets and it has 
been suggested that a greater proportion of Prevotella in the 
IM is a marker of residence in an agrarian society, whereas 
predominance of Bacteroides is indicative of an inhabitant 
of a more industrialised society [46].
In relation to carbohydrate metabolism, certain species 
are known to possess genes that encode carbohydrate active 
enzymes and can switch readily between different energy 
sources in the gut depending on their availability. NSP, oli-
gosaccharide and mucin breakdown, and fermentation by 
the IM lead to biomass, gas, and SCFA production which 
impact physiological activities, such as lipogenesis, satiety 
signalling, and the provision of energy to the colonocytes. 
Based on our review, few recent studies appear to have 
evaluated the effect of the IM composition and metabolism 
per se in relation to digestible dietary carbohydrate or fat. 
A diet high in carbohydrates leads to an increased produc-
tion of SCFA following fermentation by the IM. Acetate, 
propionate, and butyrate production is generally increased, 
whereas valerate, BCFA, and the concentration of ammonia 
are generally reduced. However, no information was found 
during the review on the IM responsible for such changes. 
However, a recent study demonstrated that a high carbohy-
drate diet modulated faecal saccharolytic bacteria including 
bacteroides and bifidobacteria [44]. Studies dealing with fat 
intake focused on the production of methylamines. Catabo-
lism of choline by the IM results in TMA formation which 
is metabolised by the liver to TMAO. Studies suggest that 
high-fat diets lead to increased production of both TMA and 
TMAO, which are possible risk factors for cardiovascular 
disease. Similarly, conversion of carnitine, which is high in 
red meat, to TMAO can occur. Concerning the composition 
of the IM, high-fat diets appear to lead to reduced diversity 
in IM. However, no information on the species impacted was 
found. More recent results also indicate that dietary con-
jugated linoleic acid metabolism in mice may be, at least, 
partially mediated by alterations in the IM composition and 
functionality [104].
In controlled human studies, variations in intake of NSP 
and prebiotics altered levels of specific taxa that selectively 
metabolise specific carbohydrate substances, such as R. 
bromii and E. rectale. In addition, levels of bifidobacteria 
and lactobacilli tend to increase, particularly with oligo-
saccharides. Few human studies were available describing 
the impact of RS on the IM and host physiology. R. bro-
mii appears to be a key species whose growth is stimulated 
upon RS starch consumption both in humans and animals. 
Furthermore, abundance of bifidobacteria, lactobacilli, 
and other species belonging to the Clostridium cluster IV 
appears to be increased and leads to the production of SCFA. 
Although in most studies, an increase was found in the total 
SCFA levels, no consistency was observed in relation with 
the type of SCFA produced following RS consumption. 
Furthermore, RS intake led to an increase in the appetite 
promoting GLP-1 and improved colonic health.
Studies have associated increased microbial richness 
with diets high in fibre, vegetables, and fruits. In controlled 
human studies consistent data exist that show a correlation 
between the intake of fibre and an increase in bifidobacteria 
and SCFAs, in particular, butyrate. This leads to lower pH 
values in the intestinal tract, which is considered beneficial to 
the host. The type and variety of SCFA produced depended 
on multiple factors, such as availability of non-digestible 
substrate, composition of the microbial community, intesti-
nal transit time, and colonic pH. Other indirect effects such 
as stimulation of GLP-1 secretion were also observed due 
to increases in SCFA following high-fibre diets. Regarding 
changes in the composition of the faecal microbiota, there 
are conflicting data, e.g., in one study Bacteroides in general 
were increased after fibre supplementation, whereas other 
studies revealed a decrease in Bacteroides intestinalis and 
Bacteroides vulgatus. Increased fibre intake and associated 
changes in metabolites and IM composition showed a posi-
tive impact on glucose and fat metabolism in humans. Of 
note also in relation to study results is the observation of 
gender differences and considerable inter-individual vari-
ation in response to dietary substrates which have implica-
tions for future study design.
There is mounting evidence that polyphenols which are 
abundant dietary constituents and possess antioxidant, anti-
inflammatory, and anti-microbial properties may exert car-
dio-, chemo-, and neuro-protective effects. However, such 
effects are dependent on the bioavailability and bioactivity 
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of these molecules. As most polyphenols exist in foods as 
esters, glycosides, or polymers, they rely on modification 
either by host digestive enzymes or those derived from the 
IM for absorption to occur. Collectively, the studies reviewed 
highlight the key role of the IM in the metabolism of simple 
and complex dietary polyphenols to produce more readily 
absorbable metabolites. As such, the IM are important in the 
potentiation of the health benefits associated with this class 
of compounds. Importantly, variation within the IM can have 
downstream consequences for the biotransformation of poly-
phenols and their subsequent effectiveness. Although some 
metabolic functions are common to a wide range of bacte-
rial species and genera, such as deglycosylation, others are 
unique to a particular species or strain. For example, daidzin 
is converted to daidzein by bacterial β-glucosidases and the 
predominant metabolites produced by human intestinal bac-
teria are equol and ODMA [105]. Among humans, 30–50% 
has the bacteria capable of producing equol and 80–90% 
harbour ODMA-producing bacteria. However, to date, only 
a few equol-forming intestinal bacteria have been identified 
and isolated from human faeces; a consortium of four human 
strains (EPC4: Enterococcus faecium EPI1, Lactobacillus 
mucosae EPI2, Finegoldia magna EPI3, and a Veillonella 
sp.-related strain), Slackia isoflavoniconvertens, Asaccharo-
bacter celatus and Adlercreutzia equolifaciens, Eggerthella 
sp. YY7918 and L. garvieae 20-92 [106–110].
In the polyphenol-related studies, in particular, a large 
amount of inter-individual variation was observed in the 
microbial metabolism and absorption of certain polyphe-
nols. This variation resulted in different host exposures to 
bioactive compounds and could explain variation in the 
effectiveness of the interventions. Indeed, research by sev-
eral authors [84, 89, 92, 95–97] demonstrated the potential 
utility of using pre- and probiotics, xylitol, arabinose or 
rice bran oil administration to manipulate IM interactions 
to alter polyphenol bioavailability/metabolism and mini-
mize this variation. In addition, a recent study using radi-
olabelled (−)-epicatechin demonstrated considerable vari-
ation in the microbial processing of this flavanol between 
humans and rats and to a lesser extent between humans 
and mice. This species-dependent variation must be con-
sidered when discussing findings from rodent studies and 
their relevance to human health [111]. Identification of 
the gene families responsible for microbial conversions 
is increasing our understanding further. For example, two 
studies have looked into identification and expression of 
genes involved in daidzein metabolism [107, 110]. Sev-
eral genes involved in the conversion of daidzein by S. 
isoflavoniconvertens have been identified and expressed 
demonstrating that they were encoding a daidzein reduc-
tase, a dihydrodaidzein reductase, and a tetrahydrodaid-
zein reductase [107]. Also, a novel NADP(H)-dependent 
daidzein reductase was purified from Lactococcus strain 
20-92 [110]. Metabolic profiling is a useful tool for inves-
tigating variations in host metabolism and IM composition 
in response to dietary intervention [103].
In conclusion, it is evident from the systematic review 
that the IM plays a major and complex role in the break-
down and transformation of the dietary substrates exam-
ined. However, recent human intervention data are lim-
ited, and results observed in relation to dietary substrates 
are not always consistent and coherent across studies. 
As many of the studies reviewed were of short duration 
with moderate numbers of subjects, care must be taken in 
extrapolating results. Direct comparison of effects between 
studies is often hampered by lack of standardisation in 
methods used and differences in degree of precision in 
identification of the microbes involved, with some stud-
ies reporting microbial changes at phyla level while oth-
ers indicating changes at species or strain level. Lack of 
full details and characterisation of dietary interventions 
and information on control of confounders applied also 
make interpretation difficult. Inclusion of pre-screening 
assessments using new tools, such as urinary markers, to 
differentiate responders from non-responders, may shed 
light on the variability of IM responses observed both in 
terms of composition and functionality. More long-term, 
well controlled, randomised, human intervention studies 
with adequately screened subjects and the use of culture-
independent microbial technologies and novel markers are 
required. Nevertheless, current evidence indicates that a 
more thorough understanding of the role the IM plays in 
the metabolism of dietary substrates at precise mechanistic 
levels, and of the dominant members of the IM and com-
munity profiles, is essential to facilitate the development 
of novel dietary strategies based on the composition and 
physiology of the IM to improve health.
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